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Current methods of objectively measuring hearing thresholds at frequencies below 
1000 Hz are not as accurate, or effective as obtaining hearing thresholds from the higher 
frequencies. The auditory nerve overlapped waveform (ANOW) was developed to allow 
accurate assessment of frequencies below 1000 Hz from the production of the cochlear 
microphonic, to develop a method of objective measure of low frequency hearing threshold. 
In the current evidence base, no one has yet successfully measured the ANOW in humans. 
This study aimed to produce the ANOW in humans to develop it as an objective measure of 
hearing threshold. 
We subjectively measured participant’s thresholds using both pure tone audiometry 
and electrocochleography. The participants were all suspected of having Ménière’s disease, 
and were undergoing transtympanic electrocochleography. We then used the 
electrocochleography needle to record our auditory responses. From these responses we 
derived the ANOW. 
Comparing the data analysed to the audiograms of the participants, we cannot 
conclude at this stage that the ANOW that we measured was purely neural from the apex of 
the cochlea in origin. The sound levels at which testing took place generally exceeded those 
levels which guaranteed that the ANOW waveforms recorded were purely neural in origin. 
From this, future studies in this area will involve stacked derived band masking to show 
frequency specificity and neural origin of the recordings. As such, the current results were not 
able to accurately predict participant thresholds. However this study has further advanced 
the technique of utilising the ANOW as an objective measure of low frequency hearing, to the 
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Chapter One: Introduction and Literature Review 
Hearing loss affects 15% or 1019 million of the world’s population, with 360 million 
people having a debilitating (moderate or worse) hearing loss (World Health Organisation, 
2015). Those with profound hearing loss (the greatest amount of hearing loss) make up 
approximately 0.3% of all those with a hearing loss, equating to approximately 20 million 
people (World Health Organisation, 2015). Hearing loss affects over 330,000 people within 
New Zealand, with that number set to double within the next 50 years (Statistics New Zealand; 
Exeter, Wu, Lee, & Searchfield, 2015). Of those with hearing loss, profound hearing loss 
affects approximately 0.01% of the total New Zealand population, or approximately 3000-
4000 people (Sanders, Houghton, Dewes, McCool, & Thorne, 2015). There are 180 to 200 
children born each year with a hearing impairment in New Zealand, and 5-11% of those are 
severely to profoundly deaf bilaterally (Digby, Purdy, & Kelly, 2014; Digby, Purdy, & Kelly, 
2015). For those with severe to profound hearing loss, cochlear implantation is an option to 
help aid hearing, speech, and language, where other options such as hearing aids may not be 
able to. As of 2014, over 600 people throughout New Zealand had received cochlear implants 
(CIs) through the Southern Cochlear Implant Programme, with over 60 adults on the wait list 
(Heslop, 2014). 
Formerly it was taken for granted that any residual acoustic hearing would be lost on 
implantation, due to cochlear damage incurred during the insertion of the electrode. 
However, due to improved surgical techniques it is now common for residual hearing to be 
preserved (Kiefer et al., 2004). There is plenty of evidence to suggest that monitoring hearing 
during surgery can alert the surgeon to early warning of any iatrogenic damage that may be 
occurring, allowing them to modify their procedure, and preserve residual hearing (Calloway 
et al., 2014; Radeloff et al., 2012). Electric hearing from the CI processors is optimised for 
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speech, but residual hearing (often aided with a hearing aid) helps with music and speech 
perception, localisation, articulation, and literacy (Gantz, Dunn, Walker, Van Voorst, Gogel, & 
Hansen, 2016; James et al., 2005; Marx et al., 2015). 
The useful residual hearing that CI patients present with is usually in the very low-
frequency range (Cosetti et al. 2013). It is these low frequencies that monitoring techniques 
have trouble with (Laureano, McGrady, & Campbell, 1995; Spoor & Eggermont, 1976). As will 
be explained in depth in later sections, a new method of recording low frequency neural 
activity has recently been published: the auditory nerve overlapped waveform or ANOW. This 
potential holds great promise for the intraoperative monitoring of CI surgeries, but so far the 
only published recordings have been those made in cats and guinea pigs (Lichtenhan, Cooper, 
& Guinan Jr, 2013; Lichtenhan, Hartsock, Gill, Guinan Jr, & Salt, 2014). 
This project began in the pursuit of the intraoperative monitoring of auditory 
potentials in CI patients. Throughout the course of this project, multiple attempts were made 
to record potentials intraoperatively. New software for this task, called “Te Pihareinga” has 
been developed by O’Beirne (O’Beirne & Bird, 2015), and although the software is working 
well, technical issues with the common-mode rejection of the amplifiers used prevented 
usable potentials from being recorded in that setting, despite multiple attempts over several 
months, and low CI patient numbers meant there were few opportunities to resolve these 
technical issues in the operating theatre setting. 
To pursue our goal of recording the ANOW in humans, we switched our focus to 
undertaking a pilot study in a patient population that underwent electrocochleographic 
assessment more frequently (four or five patients a month at Christchurch Public Hospital) 
using an established low-noise recording set-up, and a population which could also benefit 
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from examination of their low-frequency neural activity: patients with Ménière's Disease. The 
patients that are examined using ECochG at Christchurch Hospital usually have recordings 
made in both ears, which would give us the opportunity to compare ANOW thresholds with 
audiometric thresholds in both normal and Ménière's ears. 
This thesis details a pilot study that has resulted in the first published recordings of the 
ANOW waveform in five humans, improvements made to the signal processing techniques 
that halved the acquisition time for the potential, and some possible improvements to the 
technique that may be made in the future. 
Before this, however, it is important that we take a step back to understand the anatomy 
and physiology of the auditory system, the underlying neural potentials involved with 
auditory monitoring, and the pathology associated with Ménière’s disease. The following 
chapter sections will outline each of these in greater detail with a thorough review of the 
current literature. 
1.1 The auditory system 
The anatomy and physiology of the afferent and efferent auditory pathways is 
fundamental to understanding the function of the auditory system as a whole, and therefore 
auditory evoked potentials and the hearing threshold of the individual it represents. It is 
therefore the starting point for this literature review, building a basis of understanding for 
the topics investigated in this thesis. 
1.1.1 Afferent auditory pathway 
The outer, middle, and inner portions of the afferent auditory pathway transform 
sound waves from particle vibrations in the air; a mechanical signal to neural electrical signal. 
The sound waves travel down the external auditory canal to the tympanic membrane. This 
displaces the membrane, causing the ossicular chain of the malleus, incus and stapes bones 
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to concentrate this movement by a factor of 22 onto the round window of the cochlea 
(Patuzzi, 1996). This is known as impedance matching. This movement on the round window 
causes the fluid within the cochlea to create a longitudinal pressure wave. This pressure 
causes the basilar membrane to move vertically, creating a transverse travelling wave moving 
from the base of the cochlea to the apex (Von Békésy & Wever, 1960). Sound waves have 
alternating phases of rarefaction and condensation. The frequency of the stimulus interacts 
with the mass and stiffness of the basilar membrane to determine the maximal peak of the 
transverse wave, and therefore the hair cells stimulated within the cochlea, creating hair cells 
that respond to a characteristic frequency (Fettiplace & Hackney, 2006). The basal turn of the 
cochlea responds to the high frequency spectrum, while the apex responds to the lower 
frequencies humans can hear (Von Békésy & Wever, 1960). The stiffness, width, and damping 
of the basilar membrane creates the tonotopic organisation of the cochlea via a graded 
variation in its resonant frequency. The stiffness of the basilar membrane increases from the 
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apex to base, while the mass decreases from apex to the base (Oghalai, 2004). Figure 1 shows 
the structures from the outer, middle and inner ear.  
 
The organ of Corti sits atop the basilar membrane, and consists of sensory hair cells, 
known as inner hair cells (IHCs) and outer hair cells (OHCs) and supporting cells. The OHCs 
stereocillia are embedded within the tectorial membrane, which forms the top of the organ 
of Corti. When the basilar membrane is displaced, it causes the tips of the stereocillia of the 
OHCs to bend against the tectorial membrane, which is known as radial shear. Radial shearing 
causes the OHCs to fire (Billone & Raynor, 1973). The IHCs stereocillia are not imbedded 
within the tectorial membrane, and are thought to be displaced by the velocity of the basilar 
membrane movement, as opposed to the physical displacement like the OHCs stereocillia 
(Fettiplace, 2006). 
 





The cochlear is filled with three types of fluid; endolymph, perilymph, and intrastrial 
fluid (Wangemann, 2006). The fluids of the cochlea helps to regulate the process known as 
mechonelectrical conduction. It does this via the composition of endolymph and perilymph 
involving concentration gradients of potassium (K+), sodium (Na+), Calcium (Ca2+) and chloride 
(Cl⁻) (Wangemann, 2006). Endolymph is present within the scala media, and the perilymph 
within the scala tympani and vestibuli. The perilymph has a high concentration of Na+ and low 
K+ concentration. Potassium is pumped into the endolymph of the scala media from the stria 
vascularis, creating the endolymphatic potential; a high concentration of K+ between the 
Reissner’s and basilar membranes, and the surrounding cochlear fluids (a ratio of 
approximately 157mM to 6mM), as well as a low Ca2+ concentration (Wangemann, 2006). This 
potential difference allows for mechonelectrical transduction or MET; a mechanism that 
allows mechanical energy to be converted into electrical energy (Gillespie & Walker, 2001). 
Figure 2: The components of the Organ of Corti and the cochlear fluids (Hughes & Pensak, 2011) 
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In this case, oscillations from the basilar membrane deflect inner hair cells, causing MET ion 
channels within the cell membranes to open, resulting in a surge of K+ from the endolymph 
into the inner hair cell, causing a depolarisation with the possibility of an electrical potential 
(Gillespie & Walker, 2001). The ion channels responsible for MET use the gating spring model; 
the ion channel on the hair cell’s stereocillium is attached via an extracellular filament (or tip 
link) to the adjacent stereocillium, so that when they are pulled in the activating direction, 
toward scala vestibuli, the ion channel is pulled open by the filament, allowing the flow of 
ions (Gillespie & Walker, 2001). 
The efferent auditory pathway consists of the descending neural fibres, but unlike the 
afferent auditory pathway, the physiology behind it is not yet as well understood. The 
pathway starts in the temporal lobe, and generally follows the opposite of the afferent 
auditory pathway. The nerve fibres travel through the MGB, the olivocochlear system, 
through the brainstem and the IAC, to synapse with the outer hair cells and primary afferent 
neurones in the cochlea (Huffman, & Henson, 1990). 
1.1.2 Efferent auditory pathway 
The efferent auditory pathway consists of the descending neural fibres, but unlike the 
afferent auditory pathway, the physiology behind it is not yet as well understood. The 
pathway starts in the temporal lobe, and generally follows the opposite of the afferent 
auditory pathway. The nerve fibres travel through the MGB, the olivocochlear system, 
through the brainstem and the IAC, to synapse with the outer hair cells and primary afferent 
neurones in the cochlea (Huffman, & Henson, 1990). 
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The olivary complex is the thought to be an important part in the efferent auditory 
pathway. It can be divided into the lateral olivocochlear complex (LOC) and the medial 
olivocochlear complex (MOC) (Warr, & Guinan Jr, 1979). The LOC innervate the type I afferent 
nerve fibres, and in some cases the IHCs directly (Liberman, 1980a; Warr, & Guinan Jr, 1979; 
Wersinger, & Fuchs, 2011), whereas MOC neurons synapse directly onto the base of the OHCs 
(Warr, & Guinan Jr, 1979; Wilson, Henson, & Henson, 1991). While the lateral LOC efferents 
predominantly innervate the ipsilateral cochlea, 60-75% of the MOC efferents innervate the 
contralateral OHCs (Guinan, Warr, & Norris, 1983; Thompson, & Thompson, 1986; Warr, 
1997; Wilson et al., 1991). 
It is mostly agreed upon within the research that the efferent auditory pathway is involved 
with regulating the inputs from the afferent auditory pathway (Guinan Jr., 2006). Recent 




research has shown that this regulation may be either inhibitory or excitatory in nature, rather 
than being purely inhibitory as first theorised (Galambos, 1956; Le Prell, Halsey, Hughes, 
Dolan, & Bledsoe Jr, 2005; Le Prell, Shore, Hughes, & Bledsoe Jr, 2003). Activation of the 
efferent olivocochlear complex creates an inhibitory signal onto the afferent auditory nerve 
(Galambos, 1956; Gifford & Guinan, 1987). However excitatory signals have been discovered 
from the MOC contralateral neurons, and create an effect known as the anti-masking effect. 
The anti-masking effect describes the excitatory stimulus produced on the auditory nerve 
when masking noise in the form of high intensity stimuli is applied (Dolan, & Nuttall, 1988; 
Nieder, & Nieder, 1970). The resulting effect is that the auditory nerve, when high level 
masking noise is applied with a signal, produces a greater response than with the high 
intensity masking noise alone. When low level masking stimuli was applied with a target 
signal, the resulting auditory nerve response was lower than the low intensity masking alone 
(Dolan & Nuttall, 1988). This may play a role in signal to noise detection, which would help 
with situations of discriminating auditory signals in background noise (Giraud, Garnier, 
Micheyl, Lina, Chays, & Chery-Croze, 1997; Harkrider & Smith, 2005; Musiek & Baran, 2007). 
The MOC efferent nerve fibres can also have an effect on the peripheral auditory system. 
It has been found that the inhibitory responses from the MOC fibres can reduce the 
oscillations of the basilar membrane, and thus dampen the OHCs electromotile effect, and 
therefore is thought to have an influence on the cochlear amplifier (Cooper, & Guinan, 2006; 
Guinan, 2005; Guinan Jr., & Cooper, 2008; Murugasu, & Russell, 1996; Nam, & Guinan, 2011; 
Russell, & Murugasu, 1997). The LOC efferent nerve fibre influences are less well known than 
the MOC fibres, and can be difficult to assess using electrophysiology due to their relatively 
small fibres (Groff, & Liberman, 2003). Groff and Liberman (2003) found that LOC fibres may 
have an influence over the strength of auditory nerve firing, slowly increasing or decreasing 
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the neural response produced. However there is still conflicting evidence surrounding the LOC 
fibres and their excitatory and/or inhibitory role within the efferent auditory pathway, such 
as found with the opposing findings of Le Prell et al. (2003; 2005), and Darrow, Maison, and 
Liberman (2007). Le Prell et al.’s (2003; 2005) research indicates that LOC fibres are primarily 
excitatory, while Darrow et al. (2007) have found them to have an inhibitory role. Overall, the 
efferent auditory system requires further research to be done to fully understand the 
processes it is involved with within the auditory system. 
1.2 Action potentials 
The auditory system relies on a network of neurons to transfer information from the 
periphery to the central nervous system (the brain) and back, as discussed within the previous 
chapter section. It is important to understand the process of how this auditory signal 
information is conveyed once transformed into an electrical neural signal. 
“Typical” neurons have a few basic features which aide in the physiology of information 
transferral. The body of the neuron, or the soma, receives synaptic inputs from other 
surrounding neural cells, usually via the processes off the cell known as dendrites. The axon, 
surrounded by myelinating neural cells, is the main mode of passing on the electrical signal. 
The axon ends in terminals known as synapses, which connect with neighbouring cells of 
which to pass on the signal. Within the synapses, are vesicles that contain neurotransmitter, 
chemicals that can activate or inhibit an electrical potential in the connected neuron (Siegel 
& Sapru, 2006). 
The electrical potential that conveys the auditory signal through the nervous system is 
known as the action potential (AP) or compound action potential (CAP). The AP occurs across 
the neuron’s membrane, caused mainly by the concentration gradients of Na+ and K+ (Siegel 
& Sapru, 2006). Neurons contain high extracellular concentrations of Na+ (approximately 140 
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mM) and low K+ (approximately 5 mM), and high intracellular concentrations of K+ 
(approximately 140 mM) and low Na+ (approximately 12 mM) (Siegel & Sapru, 2006). The 
concentration gradient is maintained via a protein pump (Na+−K+ ATPase), so that the overall 
intracellular potential is approximately -70 mV in a resting state (Siegel & Sapru, 2006). 
 When a neuron is stimulated, the result is a change in it its intracellular potential, 
which is either excitatory (depolarising the membrane) or inhibitory (hyperpolarising it) A 
depolarisation of the cell’s membrane causes voltage gated Na+ channels to open, allowing 
Na+ to flood into the neuron, causing the intracellular potential to become even more 
positive. If the intracellular potential reaches over -55 mV, then an action potential occurs, 
causing even more Na+ to enter the cell, and rapidly making the intracellular potential highly 
positive (approximately +40 mV) (Siegel & Sapru, 2006). The AP is known as an all-or-none 
response that doesn’t alter in amplitude at the single neuron level. As the intracellular 
potential reaches a maximal positive potential, the voltage gated Na+ channels begin to 
inactivate and close. As the Na+ channels close, the voltage gated K+ channels become 
activated due to the intracellular potential, transporting K+ out of the cell. This phase of the 
AP is known as repolarising. As all the Na+ channels are closed and the K+ channels are open, 
the intracellular potential is hyperpolarised at -80 mV, which then causes the voltage gated 
K+ channels to start closing. The cellular potential then returns to its resting state of -70 mV 
(Siegel & Sapru, 2006). See figure 4 for a pictorial representation of the action potential. 
 The time of which another action potential can occur after one has just been, depends 
on the activation states of the cell’s voltage gated ion channels. The absolute refractory period 
occurs when majority of voltage gated Na+ channels are active, resulting in no chance of 
another AP being initiated. The relative refractory period occurs when the voltage gated K+ 
channels are open, and the cell membrane is hyperpolarised (approximately 2ms after the 
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original AP). It is possible for another AP to be generated during this period, however it 
requires greater depolarisation to initiate (Siegel & Sapru, 2006). 
  
The AP does not simply travel down the axon in a wave of depolarisation, this would 
take too long to pass a signal from the periphery to the auditory centres of the brain (Siegel 
& Sapru, 2006). The Schwann cells’ myelin surrounding the axon act as insulation. The 
depolarisations of the APs occur at the nodes of Ranvier, where myelin is absent, which causes 
the AP to travel down the axon by “jumping” between nodes. This is known as saltatory 
conduction, and increases electrical conduction velocity by up to 10-100 times. Other factors 
that increase conduction velocity along the axon are increase in the nerve diameter, change 
in extracellular environment, and changes in temperature (Siegel & Sapru, 2006). 
 Once the AP has reached the nerve terminals, the depolarisation causes Ca2+ to enter 
the terminals. Calcium acts to fuse the vesicles containing the neurotransmitter, glutamate, 
to the synapse membrane, and release its contents into the synaptic cleft (Berlin, 1997). The 
glutamate diffuses across the synaptic cleft to the post synaptic neuron dendrite, where it 
binds with ligand gated Na+ channels. This causes either an excitatory or inhibitory post 




synaptic potential (EPSP or IPSP) (Berlin, 1997). This influx of Na+ can then potentially cause a 
depolarisation within this neuron, and hence creating another AP if intracellular potential 
threshold is met (-55 mV), passing on the electrical signal (Siegel & Sapru, 2006). 
 Excitatory postsynaptic potentials do not necessarily result in APs being transferred 
onto that neuron. The dendrites of the neuron receive many synaptic inputs, some excitatory 
and some inhibitory, the sum of which determines if an AP will proceed. The summation of 
the inputs must reach conduction threshold (-55 mV) which will activate the voltage gated 
Na+ channels and result in an AP. EPSP can be summated by either temporal or spatial means; 
either have two or more excitations occur close together time wise, or close together on the 
dendrite (Siegel & Sapru, 2006). However an action potential alone does not convey much 
auditory stimulus information. The rate at which APs occur, as well as the number of neurons 
responding help to convey the strength of an auditory signal (Pickles, 2012). The 
measurements of these CAPs, as well as the timing, location, and summation of CAPs can be 
useful clinically to assess auditory functioning. 
1.3 Auditory Evoked Potentials 
Neural responses to auditory stimuli can be represented by different neural patterns and 
intensities, caused by the culmination of actions potentials in certain anatomical points. The 
primary sensory cells of the auditory pathway are the IHCs, which are depolarised when 
stimulated, causing an AP in the primary afferent nerve fibres, along the auditory pathway, 
to the auditory cortex. Neural responses are also sent from the central nervous system back 
out to the periphery. Measuring these neural events can be useful clinically, to objectively 
measure auditory thresholds and give indications on the functioning of the auditory pathway 




1.3.1 Electrocochleography (ECochG) 
The earliest electrical potential that can be measured from the auditory pathway is 
known as electrocochleography (ECochG), and was first described by Wever and Bray in 1930. 
The waveform of ECochG is comprised of the cochlear microphonic (CM), the summating 
potential (SP) and the compound action potential (CAP). The response gives an indication of 
the electrical activity of the hair cells and the beginnings of the auditory nerve (Hall, 2006). 
ECochG responses are evoked using stimuli of rarefaction and condensation polarity, which 
can be summed or subtracted to amplify the components of the ECochG. When the response 
to opposite stimulus polarities are summed, the SP and AP components are enlarged, while 
the CM becomes evident when the stimulus polarities are subtracted (American Speech-
Language-Hearing Association, 1988).  
 The cochlear microphonic (CM) is produced from the OHCs deflection, and results in 
an electrical potential that is an alternating current (AC) (Dallos and Cheatham, 1976). The 
overall AC electrical potential has been found to only come from the OHC receptors, and that 
any contribution from the IHCs do not significantly contribute to the CM (Choi, Chertoff, Bian, 
& Lerner, 2004; Dallos & Wang, 1974; Patuzzi, Yates, & Johnstone, 1989). The acoustic 
stimulus determines the frequency of the CM produced, as the CM copies the frequency of 
the acoustic stimulus (Patuzzi et al., 1989). The amplitude of the CM also increases with the 
intensity of the acoustic stimulus, until the maximum intensity of the potential is reached 
(Patuzzi et al., 1989). This is due to the potential reaching a saturation point, and showing 
little change with increasing acoustic stimulus intensity from this point (Johnstone, Patuzzi, & 
Yates, 1986). As the CM is at the frequency of its evoking stimulus, changing the polarity of 
the stimulus changes the polarity of the CM. When the opposing stimuli are used in 
combination (an alternating stimulus), the CM is minimised or cancelled (Katz, 2009). This can 
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be useful clinically, to assess the functioning of the OHCs, which can help to assess auditory 
neuropathy. 
 While the main contributor to the CM is the OHCs, the summating potential portion 
of the ECochG is produced mainly from the IHCs, with some contribution from the OHCs 
(Durrant, Wang, Ding, & Salvi, 1998; Zheng, Ding, McFadden, & Henderson, 1997). The 
summating potential is seen as a direct current (DC), mirroring the displacement of the basilar 
membrane (Zheng et al., 1997). Originally, it was thought that the OHCs were the main 
contributors of this potential, however SPs recorded found a basal weighting in the potentials, 
and the basal OHCs do not produce large DC potentials at higher frequencies (Russell & Kossl, 
1992). The SP copies the stimulus temporal envelope, resulting in a DC potential of the 
polarity of the stimulus, which can be positive or negative depending on the stimulus and the 
electrode placement (Eggermont & Odenthal, 1974; Davis, Deatherage, Eldredge, & Smith, 
1958, Van Deelen & Smoorenburg, 1986). The DC potential of the SP is seen prior to the CAP, 
as a deviation away from the ECochG baseline recording, and can be seen with the CM and 
CAP in figure 5. 
The compound action potential (CAP) is the sum of the action potentials produced 
from the acoustic nerve fibres (Johnstone, Alder, Johnstone, & Robertson, 1979). It is seen as 
a negative peak known as N1, followed by a positive response or P1, and then another 
negative peak known as N2 (Katz, 2009). N2 is only present occasionally, and depends on the 
intensity of the stimulus used (Gibson & Beagley, 1976). The first peak (N1) of the CAP is 
identical to the first wave (Wave I) of the auditory brainstem response (ABR), with only minor 
differences in the evoked potential source with low intensity clicks in cases of hearing loss 
(Ferarro & Ferguson, 1989; Coats & Martin, 1977). These peaks represent the beginnings of 
the auditory nerve, the portion closest to the cochlear (Moller & Janetta, 1985).  As the CAP 
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is the sum of APs from the distal cochlear nerve, the greater intensity of the acoustic stimulus, 
the more nerve fibres recruited, and therefore the greater the evoked potential (Naunton & 
Zerlin, 1976). As well as this, with increased stimulus intensity CAP latency decreases, seen as 
the most effective at lower frequencies (Eggermont, 1974). Even with minimal IHCs present, 
a CAP will still occur if the remaining IHCs are sufficiently stimulated (Spoendlin & 
Baumgartner, 1977).  
 
Each portion of the ECochG can be used to infer the integrity of the anatomical parts 
that produce this evoked potential. This can be used as part of a medical and audiological test 
battery to come to a diagnosis about the site of lesion causing an individual’s hearing loss. 
The ECochG can also be used clinically to assess audiometric threshold using tone burst stimuli 
using the AP amplitude (Spoor & Eggermont, 1976). All of the components of the ECochG can 
Figure 5: Showing (top) rarefaction and condensation responses overlaid; (left) the rarefaction and condensation 
responses subtracted to amplify the CM; (right) the rarefaction and condensation waveforms added to amplify the 




be measured for their amplitude and latency, but the amplitude is more commonly used 
clinically and within the research, as latency changes with the frequency being stimulated as 
well as the intensity of the stimulus used (Katz, 2009). Figure 6 shows the locations along the 
ECochG waveform that are measured for amplitude (Katz, 2009). Low frequencies have longer 
onset latencies than higher frequencies (Eggermont, 1974). The CAP waveforms of the 
different frequency responses changes too. At below 2 kHz, the nerve fibres are locked and 
synchronised with the onset stimulus sine wave, and related to the actual hair cell movement 
(Deatherage & Eldredge, 1959). This can be seen as a near sinusoidal wave in response the 
low frequency stimulus (Dallos & Cheatham, 1976). At 2 kHz and above, adaption occurs 
resulting in smaller AP responses over time; this is known as the on-effect, and is 
demonstrated in figure 7 (Eggermont, 1974). The reliability of ECochG recordings accurately 
measuring responses from the cochlea hair cells, and therefore threshold diminishes below 
Figure 6 (above): Indicates three possible places 
of amplitude measurement (Katz, 2009). 
Figure 7 (right): Shows the changes in both latency 
onset and wave morphology with stimulus 




500Hz (Eggermont, 1974; Laureano, McGrady, & Campbell, 1995). This represents a challenge 
to using electrocochleography for determining threshold at these low frequencies.
The different use of onset stimuli can also be utilised clinically. Click stimuli, with a 
rapid onset, stimulates a wide frequency range, and therefore stimulating more nerve fibres. 
Although click stimuli is a wide frequency stimulus, there is evidence to suggest that 
responses evoked by click stimuli primarily represent the higher frequency range, and 
therefore may not represent the nerve as a whole (Hyde, Riko, & Malizia, 1990). As previously 
stated, frequency specific tone burst stimuli can be utilised to threshold seek, although the 
resulting potential may not be as robust as rapid onset click stimulus (Pickles, 2012). This 
objective measure of hearing threshold can be used clinically to measure intraoperatively or 
to enhance wave I of the ABR (Ruth, Lambert, & Ferraro, 1988), and as one method for 
estimating hearing thresholds of young children unable to respond subjectively (Spoor & 
Eggermont, 1976). The SP can also be evoked using tone bursts, however it has been found 
that SP amplitude evoked with clicks is more reliable as a clinical measure (Coats, 1981; 
Eggermont 1979; Gibson, Moffat, & Ramsden 1977). Using SP/AP ratio can be a useful 
measure in diagnosing endolymphatic hydrops associated with Ménière’s disease, which will 
be discussed further in Chapter 1.5. The AP with an amplitude greater than 1μV is more 
reliable when using the AP/SP ratio diagnostically (Hough & Baker, 2004). 
There are a few different recording electrode sites that are able to be used for ECochG. 
They differ in how close to the evoked potentials they are i.e. how close to the cochlea, as 
well as whether they are invasive or non-invasive. The closer to the site of the evoked 
potential response the active electrode is, the more robust the signal will be, and will require 
less signal averaging to obtain a true response (Katz, 2009). The two types of placements that 
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are used for ECochG are transtympanic (invasive) and extratympanic (noninvasive). 
Transtympanic involves placing a needle electrode down the ear canal, through the tympanic 
membrane, and as close to the cochlea (promontory or round window) as possible. However 
Krueger & Wagner (1997) have shown that the precise placement of the needle does not 
impinge on the SP/AP recorded, and that any abnormalities can be attributed to pathologies, 
rather than needle placement. While other studies have shown that needle placement does 
have effect on the SP and AP, and changing position of the electrode can change the 
amplitude of the potentials (Van Deelen & Smoorenburg, 1986). While the transtympanic 
electrode yields good results it is still an invasive procedure, with possible complications. Ng, 
Srireddy, Horlbeck, & Niparko (2001) found that some of the complications faced by those 
that underwent transtympanic electrocochleography were persistent tympanic membrane 
perforation, hearing loss, otitis media and externa, hemotympanium, and pain. They however 
concluded that the complications were infrequent enough to be acceptable diagnostically, 
and that those involved tolerated the invasive procedure well (Ng et al., 2001).  
Extra tympanic does not involve piercing the tympanic membrane, but varies in 
placement site; from resting on the tympanic membrane to sitting within the external 
auditory meatus in a conducting fluid (Carpi & Migliorini, 2009). The evoked potential 
recordings from the tympanic membrane does reduce the strength of the signal detected by 
the electrode. This reduces the signal to noise ratio, reducing the measured response, and 
allowing for electrical noise to overshadow the ECochG (Kumaragamage, Lithgow, & 
Moussavi, 2015). However it is possible to record SP information, even with tone bursts, from 
a tympanic membrane placed electrode (Ferraro, Thedinger, Mediavilla, & Blackwell, 1994a). 
Ferraro, Thedinger, Mediavilla, & Blackwell (1994b) found that the SP amplitudes were 
approximately four times greater with transtympanic than with extratympanic from the same 
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ear, however the evoked potentials of both had the same morphology, allowing for diagnosis, 
regardless of decreased amplitude. Schoonhoven, Fabius, & Grote (1995) found similar 
results, and concluded that for low level stimuli, more signal averaging was required to get an 
accurate response with extratympanic placement compare to transtympanic. Bonucci and 
Hyppolito (2009) concluded that extratympanic placement was better, as although the 
amplitude was decreased and the reproducibility was lesser than transtympanic, it also 
decreased discomfort during the procedure and the electrode was easier to place. 
Noninvasive ECochG has also been found to have good inter-test reliability (Mori, Matsunaga, 
& Asai, 1981). Posterior inferior placement on the tympanic membrane has been found to 
increase amplitude of AP/SP responses, with the thought that it decreases the conduction 
pathway between the electrode and the cochlea (Cullen, Ellis, Berlin, & Lousteau, 1972; 
Mason, Singh, & Brown, 1980). 
1.3.2 Auditory Brainstem Response (ABR) 
Auditory brainstem responses (ABRs) can be used to assess the eighth cranial nerve and 
the auditory neural pathway. ABRs can be seen as a set of seven waveforms that extend from 
stimulus onset to around 15ms (Katz, 2009). The peaks and troughs of these waveforms were 
Figure 8: ABR waveform, labelled using the Jewett and Williston nomenclature (Mekjavic, 2002) 
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first named by Jewett and Williston (1971) and coincide with sums of neural activations along 
the auditory neural pathway (Katz, 2009), see figure 8 for the morphology of the ABR waves. 
Wave I is considered peripheral auditory nerve, while wave II and above is considered central 
auditory nerve, with wave V resulting from upper brainstem activation (O’Beirne, 2014). 
These waveforms are recorded by electrodes placed on the scalp, with the active electrode 
being placed on the vertex or forehead, the reference electrodes placed on the mastoid or 
the ear lobe, and the ground electrodes placed on the clavicle or the neck. 
The ABR peaks and troughs can then be used diagnostically by looking at the latency and 
amplitude of different aspects of the seven waves. Peak latencies are established by several 
mechanisms within the auditory pathway, such as delay from the cochlea to site of activation, 
filter impulse response time of the activation site, the synaptic delay between the inner hair 
cells and the auditory nerve fibres, and nerve conduction time, as well as any other synaptic 
delays within the brainstem (Katz, 2009). Amplitude can be measured from the peak of a wave 
to the trough, and can depend on the synchronisation of neural activity (such as seen with 
click compared to chirp stimuli), and also the intensity of stimulation. Hearing loss, 
pathologies, and age can also affect the peak amplitudes (Katz, 2009). Latency measures can 
include wave V latencies, comparing peak latencies between ears, measuring the latencies 
between different peaks (such as I-III, III-V, and I-V), and comparing these interpeak 
differences between ears (Katz, 2009). Amplitude measurements can include wave V 
amplitude and comparing to the opposite ear, using wave V and wave I amplitudes to form a 
ratio, and then again comparing between ears (Katz, 2009). 
Jewett and Williston (1971) found that the seven wave peaks they had measured occurred 
within 9 ms of the stimulus onset, and that waves I to V increased in magnitude. They also 
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found that the amplitudes of these waves were similar between normal hearing adults, 
around 0.6 - 1.4 μV, and similar latencies, with wave V occurring around 4.6 - 5.1 ms, however 
the morphology of the waves differed between participants (Jewett & Williston, 1971). 
Salamy, McKean, and Buda (1975) looked at the differences in latencies between adults and 
infants. They found that from birth with increase in age, the latency of wave V decreased, and 
by around age 2.5 years old responses were adult like in latency (around 5.5ms). They found 
that waves I to IV were also prolonged in younger participants. They concluded that peripheral 
maturity is achieved earlier than central (Salamy et al., 1975). Hecox and Galambos (1974) 
found very similar results to these in their ABR latency experiment with adults and infants, 
but also that latency increases with decrease in stimulus (click) intensity. Starr, Amlie, Martin, 
and Sanders (1977) looked specifically at newborn latency of wave V, and found again that 
latency decreased with maturation, for example at 65 dB SL presentation of click stimulus, 
wave V peak was present at 9.9ms at 26weeks gestation, and 6.9ms at 40weeks. During their 
study they found five children whose ABRs were abnormal, with delayed latency or altered 
amplitude at normal presentation levels. These children were found to have varying disorders 
of the brainstem and central nervous system. They go onto suggest that auditory brainstem 
potentials allow for an objective measurement of infant sensory function (Starr et al., 1977). 
ABR can be used clinically to objectively detect hearing loss that may be present in young 
children, or adults who are unable to respond to subjective threshold testing. Cone-Wesson, 
Dowell, Tomlin, Rance, and Ming (2002) used click ABRs to predict hearing loss in children, 
compared to auditory steady state responses. They found that click ABRs were slightly better 
at predicting thresholds, and that tone burst ABR was also a good predictor of adult 
thresholds. This can then be used as a screening tool to pick up any children with a hearing 
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loss; such is as done with the new born hearing screen. Mason and Herrmann (1998) used 
ABR to screen 10,372 infants for hearing loss. They found that it had a 96% success rate, and 
that those infants that were identified and amplified before 6 months had normal speech and 
language development (Mason & Herrmann, 1998). McGee and Clemis (1981) found that 
conductive losses can cause a shift in wave V latency intensity function, which correlates with 
the air bone gap found in the audiogram. However when there is a mixed loss, the wave V 
latency due to the sensorineural/retrocochlear aspect of the loss may be masked by the 
conductive component. Starr and Achor (1975) used ABRs to evaluate the usefulness in 
identifying neurological conditions. They found that ABRs were useful in localising tumours in 
the brainstem, demyelination of the brainstem, as well as decreased blood flow to the 
brainstem (Starr & Achor, 1975). 
Different stimuli can be used to elicit ABRs. Typically click stimuli activate the high 
frequency region of the basal part of the cochlea, found to be linked with auditory thresholds 
at 2 kHz and 4 kHz (Folsom, 1984; Gorga et al., 2006; Hyde, Riko, & Malizia, 1990). It is this 
that drives the wave V peak latencies. However when there is a high frequency hearing loss, 
the apical low frequency part of the cochlea produce more of wave V, causing a longer latency 
(Katz, 2009). Chirp stimuli are frequency swept to compensate for this basilar membrane 
travelling wave delay that clicks produce (Chertoff, Lichtenhan, & Willis, 2010). Chertoff et al. 
(2010) found that chirp stimuli had shallower latency intensity functions in compound action 
potentials, compared to clicks. They concluded that this was due to auditory nerve fibres 
responding more in unison with chirp stimuli than clicks, due to the frequency compensation 
(Chertoff et al., 2010). Riedel and Kollmeier (2002) found that chirps resulted in larger wave 
V amplitudes for all levels, and resulted in better ABR results compared to clicks. They also 
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concluded that this was due to greater activation of the high and low frequency neurons 
simultaneously, as opposed to high frequency activation followed through to low frequency 
activation as with clicks (Riedel & Kollmeier, 2002). Maloff and Hood (2014) found that chirps 
increased the peak to peak amplitude of wave V, especially at lower intensities, and that chirp 
stimuli were closer to estimating hearing thresholds than clicks. However the most robust 
ABRs are best produced with transient stimuli with a rapid onset, which causes synchronous 
firing of a great number of neurons, creating a stronger response recorded (Hall, 2006). 
1.3.3 Direct Eighth Nerve Monitoring (DENM) 
Direct eighth nerve monitoring (DENM) is the measurement of the collective evoked 
potential from the vestibulocochlear nerve (CN VIII). The measurement of this potential was 
first developed by Moller and Jannetta (1983). This monitoring technique is only able to be 
used during surgery which allows access to the cerebellopontine angle (CPA), as the active 
electrode needs to be placed on the proximal end of the vestibulocochlear nerve, within the 
CPA. One modern active electrode used in these recordings is a C shaped electrode, made to 
sit around the eighth nerve, while allowing for the nerve to safely move out of the electrode 
in the case of movement (Cueva, Morris, & Prioleau, 1998). 
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The cochlear nerve action potentials (CNAPs) are similar in morphology to CAPs, only 
differing in location along the cochlear nerve. The response has a large positive peak (P1), 
followed by a negative peak (N1), a second positive peak (P2), and a second negative peak 
(N2), which can be seen in figure 9. Smaller neural activity can also be seen in the trace, before 
and after the CNAP, showing the neural electrical activity moving towards and away from the 
DENM electrode (Roberson, Senne, Brackmann, Hitselberger, & Saunders, 1996). CNAPs can 
be evoked using click stimuli, causing a greater response than tone burst stimuli, as it causes 
greater recruitment of neural fibres. Tone burst stimuli, however, are useful at creating 
frequency specific responses, making it possible to record audiometric thresholds (Jannetta, 
Møller, & Møller, 1984; Møller & Jannetta, 1983). 
Both amplitude and latency can be used for evaluating the CNAP. The amplitude 
measured from the DENM can vary around 5 μV to 70 μV, and changes with degree of hearing 
loss (Cueva, Morris, & Prioleau, 1998). The amplitude of the response is taken as the voltage 
difference between the trough of N1 and the peak of P1, and is a large response given to the 
proximity to the electrical source, minimising the need for large amounts averaging (Aihara 
et al., 2009). The difference in amplitude is almost a hundred fold comparing ABR and DENM 
responses (Jackson & Roberson, 2000). The onset latency of the DENM CNAP occurs within 
Figure 9: The CNAP waveform amplitude and morphology (Ruckenstein, 1997) 
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two to five seconds. Comparing this to ABR traces, the averaging of the DENM takes less time, 
and requires less averaging overall due to the intensity of the waveform. In terms of obtaining 
results, DENM is almost instantaneous, meaning that the responses can be used as a measure 
of immediate auditory functioning of the cochlear nerve (Battista et al., 2000; Danner et al., 
2004). Batista et al. (2000) commented on the latency of the DENM response, which can vary 
between individuals due to placement on the nerve. Placement closer to the cochlea, results 
in a shorter CNAP latency. Therefore, latency measures must have a reference point from an 
individual taken before comparing latency changes (Battista et al., 2000). 
1.3.4 Otoacoustic Emissions 
Otoacoustic emissions (OAEs) are not auditory evoked electrical potentials, rather 
they are auditory evoked sounds produced from the outer hair cells within cochlea. Kemp 
(1978) discovered delayed acoustic energy produced in in the ear after being present with 
click stimuli. The sounds produced were not reflections from the cochlea, and indicated a 
nonlinear mechanism within the cochlea (Kemp, 1978). The OHCs, as discussed in an earlier 
chapter, contribute to this nonlinear process, through the feedback system known as the 
cochlear amplifier, which contributes to producing the OAEs. As such, OAEs are an objective 
measure of OHC functioning, and can be used clinically to measure low level intensity 
responses. The OAEs are conducted out of the cochlea, through the middle ear, into the 
external ear canal. OAEs cannot be measured in those with mild to moderate hearing losses 
(Kemp, 1978; Prieve et al., 1993). As the responses are acoustic in response, rather than 
electrical, OAE testing must be conducted in an acoustically quiet environment to stop 
background noise interference. 
 There are three types of OAEs that are used within research and clinically. 
Spontaneous OAEs (SOAEs) are the sounds produced by random oscillation of OHCs without 
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being acoustically stimulated, which can be heard in the external auditory meatus. This occurs 
naturally in at least 30-50% of the normal hearing population in at least one frequency (Probst 
et al., 1986). SOAEs, however, are not much use diagnostically, as they only apply for very 
specific and varying frequencies in different individuals, if at all. Transient OAEs (TEOAEs) are 
sounds produced by the cochlea in response to a click or tone burst stimulation. Imperfections 
within the basilar membrane cause sounds to be echoed back, creating an OAE that is 
representative of approximately 500 Hz to 4000 Hz, with 2000 Hz to 4000 Hz being the most 
repeatable, reliable, and indicator of hearing loss (Prieve et al., 1993). TEOAEs measure an 
acoustic signal in background noise, and as such, much be performed in relatively quiet 
conditions to detect the low level OAE produced. Distortion product OAEs (DPOAEs) are 
produced by stimulating the cochlea with two primary tones, which causes intermodulation 
of the two tones overlapping in the cochlea, resulting in a third tone known as a distortion 
product, which is produced as an OAEs. These OAEs result from a broad spectrum of the 
cochlea, but are still relatively frequency specific in nature (Shera & Guinan, 2008). 
When compared, DPOAEs and TEOAEs both did equally well at diagnosing a hearing loss 
at 2000Hz, while DPOAEs predicted hearing loss better at 4000 Hz, and TEOAEs better at 
1000Hz (Gorga et al., 1993). Both DPOAEs and TEOAEs were unable to accurately predict 
hearing loss at 500Hz, and this frequency was especially effected by background noise (Gorga 
et al., 1993). Both DPOAEs and TEOAEs were found to have consistent retest reliability 
(Franklin, McCoy, Martin, Lonsbury-Martin, 1992; Gorga et al., 1993). Another study found 
that 2000 to 6000 Hz were most reliable predictors of audiometric threshold, while 
frequencies above and below were less accurate (Rogers, Burke, Kopun, Tan, Neely, & Gorga, 
2010). Overall OAEs are a good indication of absence or presence of hearing loss at 
frequencies above 1000 Hz, but unlike other evoked potential discussed, they are not able to 
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be used to threshold seek, only indicate presence or absence of OHC function. Knowing this, 
persons with middle ear abnormalities will not produce OAEs. 
1.4 An Historical Review of Evoked Potentials 
The CM was first discovered by Wever and Bray in 1930, in their experiments with cats. 
They named what they had discovered the Wever-Bray effect, and concluded that the 
waveform was from the auditory nerve. Davis and Derbyshire (1934) replicated Wever and 
Bray’s experiment and came to the conclusion that the Wever-Bray effect was not from the 
nerve, but from the cochlea. The first experiments to obtain the CM, as well as the subsequent 
waveforms in humans was conducted by Fromm, Nylen, and Zotterman in 1935, using 
transtympanic recording electrodes. Fiscii and Ruben in 1962 measured the CAP from the 
round window of the cochlea and the CNAP from the eighth cranial nerve in cats. Moore was 
the first to record the CM and CAP using noninvasive electrode in 1971. This then paved the 
way for the use of recording the CM and CAP clinically. 
Around the same time, in 1967, Sohmer and Feinmesser recorded ABR waveforms using 
noninvasive surface electrodes, while Yoshie, Ohashi, and Suzuki (1967) were conducting 
electrocochleography still using invasive techniques. The discovery by Hecox and Galambos 
(1974) that ABR could be used as an objective measure of auditory threshold in both adults 
and children, as well as noninvasively, added to the appeal of researching into ABR compared 
to ECochG for threshold estimation. The concern with noninvasive ECochG recording 
compared with noninvasive ABR recording was the signal to noise ratio, and the strength of 
the signal obtained. Extratympanic recording produces a weaker ECochG signal than 
transtympanic, making it more susceptible to interference from noise. This overall make the 
extratympanic recording less reproducible and strong than transtympanic (Bonucci & 
Hyppolito, 2009; Ruth & Lambert, 1989). Ghosh, Gupta, & Mann (2002) found that 
29 
 
extratympanic ECochG recordings had reduced sensitivity (from 100% to 90%) and reduced 
specificity (from 90% to 80%) compared to transtympanic ECochG. Kumaragamage, Lithgow, 
and Moussavi (2015) found that the main noise contributing to the degradation of the 
extratympanic signals was background biological noise and thermal noise from electrode 
impedances. Due to the noise influence that noninvasive ECochG can encounter, ECochG has 
mainly used in the research of and to diagnose Ménière’s disease, rather than in the use of 
objective threshold seeking, where invasive recording techniques can be applied 
(Kumaragamage, Lithgow, & Moussavi, 2015). 
The use of Google Ngram Viewer and PubMed results by year timeline can show the effect 
the influences mentioned above had on the uses of electrocochleography and auditory 
brainstem response within the literature. Google Ngram Viewer is a search engine that finds 
specific words or phrases found in printed books from the 1500s until 2008. The comparison 
of electrocochleography and auditory brainstem response is covered in figures 10 and 11. 
Figure 10 shows the raw data (the exact number of time the word was used in a given year) 
of the word electrocochleography per year compared to auditory brainstem response. Figure 
11 gives the same data, except that it has been smoothed for the purposes of identifying a 
trend more easily within the data. The overall trend that can be seen is the earlier use of 
30 
 
electrocochleography, until the early 1980s, where ABR became more popular within the 
written literature. 
 The other data to examine is the use of ECochG and ABR within research papers 
published. This was done through PubMed by searching for both electrocochleography and 
auditory brainstem response, and using the timeline data to create figure 12. The graph 
shows the use of the word electrocochleography compared to auditory brainstem response 
in published research papers over the years of 1960 until 2016. Again the overall trend 
shows the popularity of ABR use in research compared to ECochG, beginning in the early 
Figure 10 (above): shows raw data of the word electrocochleography (blue) compared to auditory brainstem 
response (red) usage in books from 1960 until 2008.  Figure 11 (below): The same data as in figure eleven that has 






Both Google Ngram Viewer and PubMed timeline indicate the current popularity of ABR 
compared to ECochG within the research. The suspected reasoning behind these trends has 
also been outlined; the invasive nature of transtympanic ECochG, and the better sensitivity 
and specificity of noninvasive ABR compared to noninvasive ECochG. 
1.5 Ménière’s Disease 
Ménière’s disease has a range of symptoms consisting of vertigo attacks, tinnitus, aural 
fullness, and hearing loss, and can affect one or both ears (Hughes & Pensak, 2011; 
Ruckenstein, 2010). It is described by the American Academy of Otolaryngology-Head and 
Neck Surgery (1995) in table 1 as comparing the range of symptoms felt with the possibility 
of having Ménière’s disease. Ménière’s disease can also be defined into three different stages 
defined by hearing loss associated with the disease (Kumagami, Nishida, & Baba, 1982). First 
stage: hearing recovers between attacks of Ménière’s. Second stage: a fluctuating hearing 
Figure 12: The raw data of the word electrocochleography (orange) compared to auditory 
brainstem response (blue) usage in published papers from 1960 until 2014. 
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threshold which does not recover between attacks. Third stage: a fixed hearing loss, greater 
than 60 dB HL. The attacks of vertigo give the sensation of spinning, which can last for several 
hours, also often inducing nausea and emesis. The attacks can occur in groups, over a few 
days. Hearing, aural fullness, and tinnitus can all get worse prior to an onset of an attack, but 
can recover afterward (Ruckenstein, 2010). 
Possible Ménière’s 
Disease 
1. Episodic vertigo of the Ménière’s type without documented hearing loss 
or sensorineural hearing loss (fluctuating or fixed) with disequilibrium but 
without episodes 
2. Other causes excluded 
Probable Ménière’s 
Disease 
1. One definitive episode of vertigo 
2. Audiometrically documented hearing loss on at least one occasion 
3. Tinnitus or aural fullness in the treated ear 
4. Other causes excluded 
Definite Ménière’s 
Disease 
1. Two or more episode of vertigo lasting 20 minutes or longer 
2. Audiometrically documented hearing loss on at least one occasion 
3. Tinnitus or aural fullness in the treated ear 
4. Other causes excluded 
Certain Ménière’s 
Disease 
1. Definite Ménière’s Disease, plus histopathologic confirmation 
 An alternative measure of Ménière’s is the Gibson Score. It uses the combination of 
the four main symptoms of Ménière’s and assigns points depending on the severity. A score 
of 7 or over indicates Ménière’s disease, with a maximum of 10 points possible. One point is 
given to each of the following if present: rotational vertigo; attacks of rotational vertigo 
lasting over 10 minutes; rotational vertigo associated with hearing loss, tinnitus, or aural 
pressure; sensorineural hearing loss; fluctuating sensorineural hearing loss; hearing loss or 
fluctuation associated with vertigo, tinnitus, or aural pressure; tinnitus lasting over 5 minutes; 
tinnitus fluctuating with vertigo, hearing loss, or aural pressure; aural pressure lasting over 5 
Table 1: Shows the diagnosis of Ménière’s disease from the patient’s symptoms 
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minutes; fluctuating aural pressure with vertigo, hearing loss, or tinnitus (William, 1991). The 
above methods of identifying patients with Ménière’s disease rely on their subjective 
symptoms and personal information (Hornibrook, Kalin, Lin, O’Beirne, & Gourley, 2012). 
The main identified cause of Ménière’s disease is endolymphatic hydrops, discovered 
by both Yamakawa (1938), and Hallpike and Cairns (1938) in their separate histopathology 
research. Hydrops can be described as a fluctuating excess of endolymph fluid in the cochlea 
and vestibular system, causing distortion to the fine inner structures of both the cochlea and 
the vestibular saccule (Hughes & Pensak, 2011). In some cases the Reissner’s membrane 
becomes enlarged, causing the accumulation of endolymph within the scala media to fill the 
space of the scala vestibuli. This can also lead to rupturing of the membranes within the inner 
ear, which can histologically confirm the presence of hydrops (Hughes & Pensak, 2011). Figure 
13 shows a diagram of what endolymphatic hydrops looks like within the cochlea. The exact 
cause of endolymphatic hydrops is still not fully known. 
The objective measure of detecting endolymphatic hydrops using ECochG was 
explored by Gibson, Moffat, & Ramsden (1977), Gibson, Prasher, & Kilkenny (1983), and Coats 
Figure 13: shows the effect endolymphatic hydrops has on the cochlear structures 
(Hughes & Pensak, 2011) 
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(1981), using invasive and noninvasive techniques, as well as clicks and tone burst stimuli. 
They used the SP and AP to define the difference between normal ears and with hydrops 
present, with an enlarged SP giving an indication of hydrops. Margolis, Rieks, Fournier, & 
Levine (1995) found that SP/AP ratio, and tone burst SP were useful in diagnosing hydrops. 
Clinical norms were developed from the research, currently used at Christchurch Public 
Hospital, which can be seen in table 2. The effect of hydrops, and the resulting Ménière’s 
disease, has on ECochG tone burst and click recordings can be seen respectively in figures 14 
and 15. Gibson (1993) found that the lower frequencies of 500 and 1000 Hz were more 
effective at diagnosing Ménière’s disease using the SP compared to higher frequency of 4000 
Hz. Gibson (2009) compared the sensitivity between tone burst and click ECochG for 
confirming hydrops. He found that tone burst stimuli, especially at 500, 1000, and 2000 Hz, 
was a more sensitive measure of hydrops than click stimuli (Gibson, 2009). Hornibrook et al. 
(2015) found similar results, concluding that tone burst ECochG was a more sensitive measure 
than both MRI detection and click stimulus ECochG. 






There is no definitive treatment for Meniere’s disease, but there are management 
strategies. The strategies involve trying to decrease the amount of endolymph, increasing the 
circulation within the inner ear, or attempting to remove the blockage of the endolymphatic 
duct that may be causing symptoms (Hughes & Pensak, 2011). Ruckenstein, Rutka, & Hawke 
(1991) evaluated different Ménière’s disease treatments and came to the conclusion that 
none of the supposed treatments had been shown to be effect in controlled double blind 
Figure 14: A tone burst ECochG response example of a patient with endolymphatic hydrops, 
causing an enlarged SP amplitude (Katz, 2009). 
Figure 15: A click ECochG response example of a normal patient (top waveform) and a patient with 
endolymphatic hydrops (bottom waveform), causing an enlarged SP amplitude (Katz, 2009). 
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studies. Management strategies involve either conservative measures, or surgical or 
destructive measures. Conservative methods involve a low sodium diet and diuretics to try 
and decrease the amount of endolymph. Betahistine can be prescribed in an attempt to 
reduce vertigo or dizziness (Lacour, van de Heyning, Novotny, & Tighilet, 2007). Invasive and 
destructive procedures such as endolymphatic sac surgery, gentamicin injections, vestibular 
nerve resection, or inner ear destruction can be implemented if the symptoms of Ménière’s 
have become severe, and other management strategies have been tried and failed. From 
these destructive management strategies, rehabilitation is necessary, as both sensitivity of 
hearing and balance for the effected side will be severely diminished or absent. 
1.6 Limitations to current clinical methods of monitoring thresholds 
Although there are many benefits to the current methods of monitoring thresholds using 
auditory evoked potentials, there are also some limitations, which could be improved upon 
by another method. The main methods of objective threshold measurements using auditory 
evoked potentials are discussed below. 
1.6.1 ECochG 
As discussed in chapter 1.3 ECochG is useful in its ability to compare different aspects of 
the cochlea; the functioning of the OHCs, the IHCs, and the beginnings of the auditory nerve. 
It is also one of the leading ways in helping to diagnose Ménière’s disease. However there are 
limitations to this method when it comes to objectively measuring hearing threshold. 
Laureano, McGrady, and Campbell (1995) found that lower frequencies did not correlate with 
behavioural audiometric thresholds when using an extratympanic electrode. Higher 
frequencies of 2000 and 4000 Hz did correlate, but from 1000 Hz and below, the ECochG 
became an unreliable method of measuring threshold (Laureano, McGrady, & Campbell, 
1995). Schoonhoven, Prijis, and Grote (1996) conducted a similar study, except compared 
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both extratympanic and transtympanic electrodes with pure tone thresholds. They found that 
both methods of measurement correlated with frequency specific audiometric thresholds 
except for 500 Hz by extratympanic measurement, and that extratympanic thresholds yielded 
more uncertainty. They concluded that ECochG measurements take into account cochlear 
sensitivity, but subjectively thresholds also take into account reduced temporal integration 
(Schoonhoven, Prijis, & Grote, 1996). Spoor and Eggermont (1976) found that for lower 
frequencies of 500 Hz gave greater range of differences in threshold, as well as, on average, 
predicting the subjective threshold as 10dB better than it actually was. These studies have 
found good correlation of high frequency ECochG responses with audiometric threshold, but 
poor correlation with low frequency stimuli. 
Another problem with ECochG being used for threshold stimulation is the reduced 
response with extratympanic ECochG. The response, due to the decreased amplitude, can be 
subject to other neural potentials interfering with the recording (Patuzzi, Yates, & Johnstone, 
1989). And as such, requires greater averaging to obtain a true response, requiring more time, 
and thus not being an instantaneous measure of hearing. Humphries, Ashcroft, and Douek 
(1977) found that extratympanic ECochG predicted subjective threshold with 30dB, which 
they considered to be a good indicator of threshold. Transtympanic can remove some of these 
problems, however the invasiveness of this procedure remains a problem for those not 
requiring special ear treatments i.e. those with normal auditory system functioning. 
The final consideration of ECochG is the subjective nature of the interpretation of the 
waveforms. In terms of Ménière’s disease, the SP/AP ratio can be critical in diagnosis and 
therefore management. Roland and Roth (1997) evaluated the variability of clinician’s 
interpretations of ECochG, specifically the SP and AP amplitudes. They found that the more 
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difficult or no response traces had the greatest inter-clinician variability, resulting in 
significant differences in diagnosis (Roland & Roth, 1997). 
1.6.2 ABR 
As with ECochG, ABR has problems of lower frequency not correlating to behavioural 
threshold as well as the higher frequencies. Sininger, Abdala, and Cone-Wesson (1997) found 
a high correlation between frequency tone burst stimuli and the corresponding auditory 
thresholds in infants. These results showed elevated thresholds compared with adult 
thresholds, especially with 8000 Hz, suggesting the auditory system not fully developed in 
terms of high frequency thresholds (Sininger, Abdala, & Cone-Wesson, 1997). While Sininger 
(2007) found that the responses to the low frequency tone bursts did not correlate as well to 
behavioural thresholds. Tone burst stimuli are preferred in estimating threshold, as click 
stimuli produce a response from the auditory nerve as a whole, with a possible bias for the 
higher frequencies due to phase cancellation of responses from lower frequencies (Hyde, 
Riko, and Malizia, 1990; Katz, 2009). It has been found that ABR can be an accurate 
measurement of auditory thresholds from 500 to 4000 Hz in neonates, young children, and 
adults (Stapells, 2000; Stapells & Oates, 1997). Threshold measurement at 500 Hz in neonates 
is attempted using a correction factor, to allow for inaccuracy at this frequency, as providing 
estimated hearing amplification at this frequency is better than none at all. Stapells (2000) 
found that the correction factor used often varies among patients, which adds a level of 
uncertainty to the actual threshold, as well as any hearing aid amplification that may be 
prescribed. As a result ABR is commonly used as an objective threshold measure in neonates 
and young children who are yet unable to subjectively respond. This has advantaged over 
ECochG, as ABR yields good responses using noninvasive electrode placement. 
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Like ECochG responses, auditory brainstem responses need to be averaged to highlight 
and enhance the ABR waveform within the background electrical and myogenic noise (Hall, 
2006). The responses can be biased by myogenic potentials, which are larger in amplitude (as 
seen with the PAMR or post auricular muscle response), which can then influence the 
resulting waveform (Don & Elberling, 1994). This is why the testing must occur while the 
patient is at rest, and with eyes closed. Bayesian weighting to the responses can help to 
minimise the noise recorded, helping to improve the strength of the response, overall 
reducing averaging time (Don & Elberling, 1994). 
1.7 Auditory Nerve Overlapped Waveform (ANOW) 
The Auditory Nerve Overlapped Waveform (ANOW) was first defined by Lichtenhan, 
Cooper and Guinan (2013). It is described as a neural response obtainable from what is usually 
considered the cochlear microphonic waveform. If the cochlear microphonic is produced with 
a low frequency tone burst, and then averaged with the opposite polarity CM elicited using 
the same frequency, the overall CM gets abolished, and produces a neural response that is 
twice the tone cycle. This is the auditory nerve overlapped waveform (ANOW).  
Lichtenhan, Cooper, and Guinan Jr. (2013) designed the study to develop a method of 
objectively measuring thresholds accurately below 1000 Hz, as both ECochG and ABR do not 
accurately do this. They used the reasoning described in previous papers from Henry (1995), 
Eggermont (1974), Ferraro, Blackwell, Mediavilla, and Thedinger (1994) to try and quantify 
the technique to a clinically viable test. At low frequencies the OHCs respond to stimuli as a 
sinusoidal wave almost copying the stimulus frequency (Dallos & Cheatham, 1976). While the 
underlying neural response to low frequency stimuli is to activate with one polarity of a 
stimulus wave, causing IHCs depolarise, and with the other polarity of the wave, to stop firing. 
This is known as phase locked responses (Palmer & Russell, 1986). 
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Lichtenhan et al. (2013) measured the CM within cats at 300, and subtracted the 
waveforms of opposite polarity, to leave the underlying (phase locked) neural component. 
This resultant waveform is what they termed the ANOW, and can be seen as twice the cycle 
of the overlying cochlear responses, similar to the auditory nerve neurophonic residual, as 
described by Henry (1995). The ANOW can be seen in figures 16 and 17, from the Lichtenhan, 
Cooper, and Guinan Jr. (2013) paper. They compared the measured ANOWs from 300 to 1000 
Hz with single auditory nerve fibre responses at the same frequencies. This showed that the 
ANOW is a useful measure from 700 Hz and below. From their work, in combination with 
Henry’s (1995) paper, they conclude that the ANOW is a useful technique to be developed 
further as a measure of low frequency neural auditory threshold.  
Lichtenhan, Hartsock, Gill, Guinan Jr, and Salt (2014) examined the neural origins of the 
ANOW. They used tetrodotoxin injected into the cochlear apex to slowly stop neural 
functioning from the apex to the base in guinea pigs. The frequencies of 353, 500, and 707 Hz 
were tested. They found that the cochlear responses that they were recording from the 
Figure 16: Shows the two CMs of opposite polarity 
(A & B), and the ANOW (C) of the averaged top 
traces (Lichtenhan et al., 2013). 
Figure 17: Shows the ANOW obtained from different low 
frequency stimuli. The wave cycles to the right of the 
ANOWs shows the double tone cycle produced from the 
original stimulus (Lichtenhan et al., 2013). 
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guinea pigs were not purely from the OHCs, and that the summed responses produced the 
CM, not the ANOW, as was previously thought in the Lichtenhan et al. (2013) paper. They 
used a very similar, but different technique from Lichtenhan et al. paper (2013) to produce 
the ANOW. The ANOW was achieved by summing the two cochlear responses of diffing 
polarities, smoothing the sum trace, then subtracting it from the original sum, leaving only 
ANOW (double the stimulus frequency) around a baseline of zero. This can be seen in figure 
18. From this study they concluded that the ANOW was neural in origin, and originated from 
the apex (low frequency) of the cochlea (Lichtenhan et al., 2014). 
Kaf, Abdelhakiem, Zahirsha, and Lichtenhan (2015) discuss the possible implications of 
using ANOW in the diagnosis of Ménière’s disease. They concluded that low frequency 
responses were more efficient at diagnosing Ménière’s disease, however current methods of 
threshold monitoring were not accurate at measuring low frequency hearing loss (Kaf et al., 
2015). They also stated that within the current research of ANOW results had only been 
Figure 18: (A) shows the cochlear response. (B) Cochlear response of opposite polarity. (C) The difference 
between A & B, resulting in the CM. (D) The average of A & B. (E) the smoothed response of D, can be seen as 




obtain from animal models, and that further development would be required to take this 
technology for use in human subjects, and in diagnosis for Ménière’s disease (Kaf et el., 2015). 
Choudhury, Fitzpatrick, Buchman, Wei, Dillon, He and Adunka (2012) researched into the 
use of the auditory nerve neurophonic or ANN, which is similar to the ANOW, and developed 
from the same past research. They recorded electrical potentials from the round windows 
during cochlear implantation in humans to investigate the preservation of residual hearing. 
They measured the CM, SP, CAP, and ANN intraoperatively. From this they concluded that 
they were able to measure the hair cell and neural states of the participants, especially at 
frequencies lower than 1000 Hz. However it should be noted that while the Choudhury et al. 
(2012) paper claims that the ANN they measured was from auditory neural activity from the 
round window in humans, only Lichtenhan et al. (2014) demonstrated that what they 
recorded (the ANOW) was purely neural in origin. The Choudhury et al. (2012) paper also 
involved a highly invasive surgical measure of reported neural activity prior to cochlear 
implantation, not practical to those patients not having their round window surgically 
exposed. 
1.8 Aims and Hypothesis 
The aim of this study is to advance the techniques formed in the animal models of the 
Lichtenhan et al. papers (2013; 2014), and develop the use of the ANOW in humans, 
specifically in those with Ménière’s disease, as suggested in Kaf et al. (2015). We aim to gain 
some normative data from the participants with suspected Ménière’s disease, as well as 
objectively track their threshold and compare to their subjective thresholds, and their ECochG 
responses. This will allow us to develop both the technique of aiding current subjective 
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methods of diagnosing Ménière’s disease, as well as further developing the serious clinical 
need for objective low frequency threshold monitoring. 
We will compare both neural and hair cell functioning from our results (CM compared to 
ANOW), and hope to find a difference between those affected with Ménière’s disease, and 
those with normal cochlear pathology. We also hope to develop the ANOW monitoring 
technique so it can be applied to not only those with suspected Ménière’s disease, but those 
with normal hearing, other auditory system pathologies, and also to be used intraoperatively. 
Based upon the current minimal literature available on the topic of ANOW, we 
hypothesise that the ANOW monitoring technique will accurately predict thresholds at lower 
frequencies, which current methods are not capable of. We also hypothesise that the ANOW 
norms developed in this study will be the beginning to a clinically viable low frequency 




Chapter Two: Verification of Equipment 
2.1 Equipment Setup 
A laptop containing the software for this experiment, was connected via USB port to 
an electrically isolated, battery powered preamplifier (NIcDAQ9174 Chassis). This 
preamplifier contained an analog input (NI9222) and an analog output (NI9269). Both input 
and output sites contained four channels. The output from this preamplifier connected to a 
battery powered Rolls Stereo mini mx 28 amplifier, which amplified the signal from the analog 
output unit and drove the magnetically shielded headphones. The electrodes connected to 
the participants feed into an electrically isolated, mains powered amplifier, which connected 
into the NIcDAQ9174 Chassis preamplifier analog input. A connection also ran between the 
input and output of the preamplifier, acting to synchronise and trigger. The Rolls Stereo 
amplifier was used to drive the headphone output as the NI9269 output was not capable. This 
amplifier contained adjustable output amplification dials, the calibration of which will be 
discussed in following chapters. The amplifier that fed into the NIcDAQ9174 Chassis 
preamplifier analog input was the Amplaid MK 15, which was also included in the recording 
of ECochG signals, via the electrodiagnostic system (Amplaid MK 15, Milan, Italy). 
2.2 Software 
The electrophysiological data was recorded using custom-written intraoperative 
monitoring software called Te Pihareinga (O’Beirne, 2015). The software presents chained 
stimuli at multiple frequencies and intensities, which allows waveforms obtained using 
different stimuli to be reliably compared (as they are recorded concurrently, thereby limiting 
the influence of differences in recording conditions and noise levels). In the initial recordings 
(Participants 1 to 3), the averaged ECochG waveforms (n = 300 averages) were saved to tab-
delimited text files for later processing. However, in later recording sessions (Participants 4 
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and 5) this processing was incorporated directly into the software and the ANOW waveforms 
were saved directly along with the averaged ECochG recordings. 
As illustrated in Figure 19 below, the following steps of processing were applied: 
1. DC offsets (calculated over the 5 ms prior to the stimulus onset) were first 
removed from both the condensation (CON) and rarefaction (RAR) waveforms. 
2. The RAR waveform was subtracted from the CON waveform and divided by two to 
produce the difference (DIFF) waveform. The DIFF waveform accentuates the 
cochlear microphonic, and attenuates neural activity. 
3. The CON and RAR were added together and divided by two to form the SUM 
waveform. The SUM waveform accentuates neural potentials and cancels the 
cochlear microphonic. 
4. The SUM waveform was then smoothed to remove any residual compound action 
potential or summating potential. This SUMsmoothed waveform was produced by 
applying a bandpass filter (0.01 Hz to 525 Hz, 3rd order Butterworth), reversing the 
filtered waveform in the time domain, repeating the filtering, and then returning 
the waveform to its normal orientation in time. This double reversal process 
helped eliminate any phase shifts imposed by the filters. 
5. The SUMsmoothed waveform was then subtracted from the SUM waveform to 





Figure 19: Data from Participant 3 (525 Hz, 94 dB peSPL) illustrating the processing applied to 
derive the ANOW waveform. The noise floors reported and plotted in this thesis refer to those of the 
ANOW trace, recorded in the 5 ms prior to stimulus onset. 
 
As illustrated in Figure 20 below, a further averaging step was performed to improve 
the noise-floor of the recording. The region of the waveforms between 8 and 26 ms was 
divided into as many whole single cycles as would fit (i.e. 6 for 360 Hz, 9 for 525 Hz, and 13 
for 725 Hz). Averaging these individual single cycles together further improved the noise floor 
by factors of 2.4 (√6), 3 (√9), and 3.6 (√13) respectively. The waveform RMS amplitude 
measures reported and plotted in this thesis therefore consist of a mean and standard 
deviation, the n of which is either 6, 9, or 13 depending on the frequency (360, 525, or 725 
Hz). 














Figure 20: Illustration of the segmentation procedure for single-cycle analysis of the DIFF and 
ANOW waveforms. In this 525 Hz recording (94 dB peSPL) from Participant 3, averaged DIFF and 
ANOW waveforms (n = 302) were divided into 9 single cycles which were then averaged together (total 
n = 2718).  
2.3 Calibration of Headphones  
The output level and frequency response of the combination of the audio amplifier 
and headphone were measured using a Brüel & Kjær Type 4128 Head and Torso Simulator 
(HATS) connected to a Brüel & Kjær 7539 5/1-ch. Input/Output Controller Module. Sinusoidal 
voltage signals of 500 mV pp at varying frequencies were produced by the NI 9269 analog 
output module for this analysis, and enabled calibration of the output tone bursts in dB peSPL.  
Comparison of tone-burst evoked potential thresholds to human audiometric 
thresholds would require measurement of peak-to-peak equivalent Reference Equivalent 
Threshold Sound Pressure Levels (peRETSPLs) from a large number of normal-hearing 
individuals using the 30 ms tone bursts played through the supra-aural headphones. Due to 





9 single cycles used in
averaging process for 525 Hz
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the late stage at which this equipment was selected, such calibration was unable to be 
performed.  
 
Figure 21: Block diagram of the experimental set-up used to elicit and record the ANOW waveform 
from human participants. 
 
 
Figure 22: This figure adapted from Hornibrook et al. (2012) shows part of the experimental set-up 
and the placement of the transtympanic electrode. An analog output from the Amplaid MK15 
biological amplifier was fed to the NI 9222 analog input unit shown in Figure 22.  
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The headphones were placed on the head and torso simulator (HATs), which allowed 
measurement of the continuous sine wave output for the input signal. The input was a 500mV 
peak to peak amplitude driven into the headphones via the amplifier. HATs provides a way of 
realistically reproducing the acoustic properties of the average adult human head and torso.  
 
Figure 23: Frequency response of the combined Rolls audio amplifier and supra-aural headphone 
combination for a 500 mV pp sinusoid. Frequencies used in ANOW testing are shown by red circles. 
 
The integration of the headphone calibration data into the testing protocols took 
place subsequent to the final data collection session. Therefore, one limitation of the study 
presented here is that the sound levels at which testing took place generally exceeded the 65 
dB SPL level which in the guinea pig ensures that the ANOW waveforms recorded are purely 
neural in origin (Lichtenhan et al., 2014). The corresponding level in human participants is still 
unknown. 
In addition, the calibration process revealed that amplifier settings used for 
Participants One and Two were such that acoustic stimuli were significantly distorted at the 
360 Hz = 86.4
525 Hz = 96.9





























500 mV pp sinusoid
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intensities tested, rendering the meaningful interpretation of their data impossible. For this 




Chapter Three: Investigations into the Auditory Nerve Overlapped Waveform 
3.1 Transtympanic Electrocochleography in Suspected Ménière’s Patients 
3.1.1 Participants 
Participants were recruited through Mr. Jeremy Hornibrook (Otolaryngologist). All the 
participants were taking part in a routine transtympanic ECochG as part of the diagnosis for 
suspected Ménière’s disease. There were no exclusion criteria for this study. 
3.1.2 Ethical Considerations 
Ethical approval from the Southern Health and Disability Ethics Committee was granted on 18th 
July 2014 (Ethics Ref: 14/STH/92). Written informed consent was obtained from each participant 
prior to testing (Appendix), and participant confidentiality was strictly maintained in accordance 
with the conditions outlined in the ethics application. 
3.1.3 General Outline of Procedure 
3.1.3.1 Pre-Electrocochleography Hearing Test 
Testing occurred in sound treated rooms, at Christchurch Public Hospital. All testing was 
conducted by either Ms Ashleigh Allsop, a Master of Audiology Student; or an MNZAS 
audiologist employed by the Canterbury District Health Board prior to non-invasive 
electrocochleography. Testing consisted of: 
1. Otoscopy and full pure tone air- and bone- conduction audiometry bilaterally, 
including the standard audiometric frequencies. Air conduction frequencies tested 
included 0.25 to 8 kHz in half octave steps. Bone conduction was measured at 0.5 to 
4 kHz in one octave steps. Thresholds were measured using the Modified Hughson-
Westlake procedure, in 5dB steps. A Grayson-Stadler GSI 61 clinical audiometer was 
used to present the stimuli to the participants. ER-3A insert earphones were used to 
present the standard audiometric frequencies (unless contraindicated), and Radioear 
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B-71 bone conduction vibrator was used to present bone conducted pure tone 
audiometry. When interaural attenuation between the air conduction of the test ear 
and non-test ear was exceeded, or bone conduction exceeded air conduction by 15dB 
HL, then narrow band masking noise was applied to the non test ear to mask. 
2. Tympanometry was also conducted using Grayson-Stadler GSI Tympstar 
tympanometer, using 226Hz probe tone at 200daPa/s sweep rate. Tympanometry was 
classified using the Jerger classification system. 
3.1.3.2 Transtympanic Electrocochleography 
All testing occurred in the Electrocochleography room of the Audiology department 
at Christchurch Public Hospital. Participants were firstly instructed on the procedure for 
transtympanic electrocochleography by Mr Jeremy Hornibrook. They were instructed to 
“relax, close eyes, and maintain head position” whilst in the supine position. The participants’ 
external auditory meatus and tympanic membrane were observed through otoscopy, and any 
debris carefully removed prior to electrode placement. The skin of the participant was 
prepared using abrasive techniques to the cheek, high forehead, and both mastoids. 
Electrodes were then placed on the cheek or forehead (ground and indifferent electrodes) 
and on the contralateral mastoid (non-inverting electrode). The skin electrodes used were 
Ambu® Blue Sensor N Ag/AgCl ECG electrodes. The transtympanic electrode acted as the 
active, inverting electrode for the ECochG recordings. 
Phenol, an analgesic was placed within the participant’s ear canal onto the tympanic 
membrane, to reduce the discomfort of the procedure. The electrodes used were TECA™ 
Disposable Monopolar Needles (CareFusion, WI, USA) which were 37 mm long and 28 gauge 
diameter. The electrodes were placed by Mr. Jeremy Hornibrook, an Otolaryngological 
surgeon. The electrode was placed to rest on or near the promontory of the cochlea. The 
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electrode was then held in place by the custom made headphone holder, and the 
magnetically shielded supra-aural headphones placed over this (see figure 22). 
The software and equipment set up used in this study is described in detail in Chapter 
2. The software used in this study is custom designed to record evoked potentials, and was 
used to generate the stimuli and record the responses of ECochG. The software is run through 
a laptop, which is connected to an electrically isolated preamplifier, which was connected to 
the electrodes on the patient. The recordings were obtained by Ms Ashleigh Allsop and Assoc 
Prof Gregory O’Beirne. The stimuli used was primarily frequency specific tone bursts 
presented through the supra-aural earphones. The traces recorded for this study were 
collected after the otolaryngologist and charge audiologist had finished conducting their own 
electrocochleography. The equipment amplifier used by the otolaryngologist was able to be 
unplugged from the electrodes connected to the patient, which was then connected to the 
equipment used for this study. 
The software recorded the raw ECochG traces, and saved them to the laptop for later 
analysis. A number of recordings were made, including the response threshold, the latency 
and amplitude of the ECochG compound action potential and low frequency neural responses 
in the form of the auditory nerve overlapped waveform (ANOW).  
3.2 Individual Cases 
All participant data was analysed using Equipment described in Chapter 2. 
3.2.1 Case One 
 Participant One was a 70 year old male who presented with a fluctuating hearing loss 
in his left ear, with a persistent tinnitus. He did not have any vertigo or aural fullness. He 
presented with Type A tympanograms in bilaterally indicating normal middle ear functioning. 
Audiometry revealed essentially normal hearing in the right ear, and a fluctuating loss in the 
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Table 3: Participant One’s ECochG Results 
left ear ranging from slight to moderate sensorineural loss on separate testing occasions. His 
audiogram from the day of testing is presented in figure 24. ECochG testing using click stimuli 
showed no significant increase in the SP/AP ratio in either ear. ECochG testing using tone 
bursts stimuli showed no significant increase in the SP amplitude at any frequency as per 
Gibson’s norms. The overall pattern of results is consistent with no hydrops in either ear. The 
ECochG results are presented in table 3, indicating that Ménière’s disease is not likely the 
cause of Participant One’s symptoms.  
 
 
500 Hz 1000 Hz 2000 Hz 4000 Hz 
Tone 
Bursts 
Right SP Amp (μV) 0.22 4.92 1.52 2.56 
Gibson Sig. Level (μV) 2.0 6.0 9.0 9.0 
AP Amp (μV) 3.56 5.76 5.36 8.76 
SP/AP ratio (%) 6.2% 85.4% 28.4% 29.2% 
Left SP Amp (μV) 2.0 5.16 5.80 2.60 
Gibson Sig. Level (μV) 2.0 6.0 9.0 5.0 
AP Amp (μV) 4.32 7.84 9.08 6.84 
SP/AP ratio (%) 46.3% 65.8% 63.9% 38% 
Clicks Right SP Amp (μV) 5.00 
Figure 24: Participant One’s audiological results; right ear showing essentially normal hearing, the 
left ear indicating a normal to mild sensorineural hearing loss 
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AP Amp (μV) 29.50 
SP/AP ratio (%) 16.9% 
Left SP Amp (μV) 3.0 
AP Amp (μV) 17.80 
SP/AP ratio (%) 16.9% 
 
Participant One’s data was analysed and graphed using the same methods as the other 
participants. Unfortunately, the responses recorded from Participant One were derived from 
distorted acoustic signals containing frequency components in addition to those specified, 
which did not permit analysis of DIFF and ANOW responses. 
3.2.2 Case Two 
Participant Two was a 37 year old female. She was referred to the otolaryngology 
department in mid- 2015 with a sudden low frequency hearing loss in her left ear. She also 
experienced a loud tinnitus associated with the loss, and a sore throat and headache prior to 
the loss. She did not have any vertigo or aural fullness. She also did not have any prior noise 
exposure, ototoxic medications, or any other ear related medical history. Balance and 
vestibular ocular tests were normal, and her MRI was unremarkable. She presented with a 
Type A tympanogram in her right ear indicating normal middle ear functioning, and were 
unable to obtain a seal on her left ear. She has not presented with any middle ear pathologies 
in the past. Audiometry revealed normal hearing in her right ear, with a moderately severe 
rising to normal sensorineural hearing loss in her left ear. This data is presented in figure 25. 
ECochG testing using click stimuli showed no significant increase in the SP/AP ratio in either 
ear. ECochG testing using tone bursts stimuli showed no significant increase in the SP 
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Table 4: Participant Two’s ECochG Results 
amplitude at any frequency as per Gibson’s norms. The overall pattern of results is consistent 
with no hydrops in either ear. The ECochG results are presented in table 4. 
500 Hz 1000 Hz 2000 Hz 4000 Hz 
Tone 
Bursts 
Right SP Amp (μV) - 1.28 3.72 5.04 
Gibson Sig. Level (μV) 2.0 6.0 9.0 9.0 
AP Amp (μV) - 5.36 11.32 12.40 
SP/AP ratio (%) - 23.9% 32.9% 40.6% 
Left SP Amp (μV) - - 1.68 4.0 
Gibson Sig. Level (μV) 1.0 6.0 5.0 9.0 
AP Amp (μV) - - 4.56 10.0 
SP/AP ratio (%) - - 36.8% 40% 
Clicks Right SP Amp (μV) 9.72 
AP Amp (μV) 34.76 
SP/AP ratio (%) 28% 
Left SP Amp (μV) 8.10 
AP Amp (μV) 37.30 
SP/AP ratio (%) 21.7% 
 
Participant Two’s data was analysed and graphed using the same methods as the 
other participants. Unfortunately, as with Participant One, the responses recorded from 
Participant Two were derived from distorted acoustic signals containing frequency 
Figure 25: Participant Two’s audiological results; right ear normal hearing, the left ear indicating a moderately severe 
sensorineural hearing loss in the low to mid frequencies rising to normal in the high frequencies 
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components in addition to those specified, which did not permit analysis of DIFF and ANOW 
responses. 
3.2.3 Case Three 
 Participant Three was a 46 year old female. In mid- 2015 she experienced a vertigo 
attack, with a feeling of nausea and aural fullness in her right ear, which persisted for three 
days. She then developed tinnitus in her right ear following this episode. There was a 
significant decrease in her low frequency hearing of her right ear following the attack also. 
Balance and vestibular ocular tests were normal. She had no other prior relevant medical 
history. She presented with Type A tympanograms bilaterally, indicating normal middle ear 
functioning. Audiometry revealed normal hearing sloping to a mild high frequency 
sensorineural hearing loss in her left ear, and essentially normal sloping to severe high 
frequency sensorineural hearing loss in her right ear. Her pure tone audiometry from the day 
of testing is presented in figure 26. ECochG testing using click stimuli showed no significant 
Figure 26: Participant Three’s audiological results. The right ear showing essentially normal hearing sloping to a 
severe high frequency sensorineural hearing loss; the left ear indicating normal hearing through the low to mid 
frequencies, sloping to a mild sensorineural hearing loss in the high frequencies. 
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Table 5: Participant Three’s ECochG Results 
increase in the SP/AP ratio in either ear. ECochG testing using tone bursts stimuli showed a 
significant increase in the SP amplitude at 1000 Hz and 2000 Hz in the right ear only, as per 
Gibson’s norms. The overall pattern of results is consistent with hydrops in the right ear only. 
The ECochG results are presented in table 5.  
 
500 Hz 1000 Hz 2000 Hz 4000 Hz 
Tone 
Bursts 
Right SP Amp (μV) 2.48 17.74 12.84 2.4 
Gibson Sig. Level (μV) 2.0 6.0 7.0 5.0 
AP Amp (μV) 5.60 16.62 15.94 4.0 
SP/AP ratio (%) 44.2% 6% 80.5% 60% 
Left SP Amp (μV) 0.68 2.20 2.36 1.72 
Gibson Sig. Level (μV) 2.0 6.0 9.0 9.0 
AP Amp (μV) 5.12 6.32 8.52 9.12 
SP/AP ratio (%) 13.2% 34.8% 27.7% 18.9% 
Clicks Right SP Amp (μV) 9.22 
AP Amp (μV) 26.66 
SP/AP ratio (%) 34.6% 
Left SP Amp (μV) 13.50 
AP Amp (μV) 57.60 





level (dB peSPL) 83 73 63 
Mean ANOW amplitude (nV RMS) 69 53 40 
StdDev ANOW amplitude (nV RMS) ± 9 ± 11 ± 4 
Mean DIFF amplitude (nV RMS) 2743 887 323 
StdDev DIFF amplitude (nV RMS) ± 194 ± 118 ± 71 
n (sub-averages) 6 6 6 
 
 
Table 6: Mean (± standard deviation) RMS amplitudes for Participant 3’s 360 Hz 
right-ear ANOW and DIFF waveforms at three intensity levels. 
Figure 27: Participant 3’s 360 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in 
the right ear at 83, 73, 63 dB peSPL. Plots B, D, and F, represent zoomed-in versions of the waveforms 
in A, C, and E respectively. The bold traces represent the mean overlaid waveform (n=1818) derived 




























































































F. 63 dB peSPL
Participant 3 - 360 Hz (right)
1 cycle. Blue = DIFF. Red = ANOW
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The overall data from participant Three indicated the ANOW was present for 360 Hz 
in her right ear. Presence of the CM can be seen in all recorded cases in the DIFF waveform, 
seen in figure 27. At 360 Hz, the presence of the CM occurs from around 300 nV RMS, with 
increasing amplitude from 63 dB peSPL. At 360 Hz, the ANOW can be distinguished from the 
noise floor between at 73 dB peSPL (but not 63 dB peSPL) with an amplitude of 53 nV RMS, 
as seen in figure 28. 
Figure 28: Input/output functions for Participant 3’s 360 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). 














Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)

















Participant 3 - 360 Hz (right) 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)




level (dB peSPL) 94 84 74 
Mean ANOW amplitude (nV RMS) 117 77 45 
StdDev ANOW amplitude (nV RMS) ± 15 ± 13 ± 11 
Mean DIFF amplitude (nV RMS) 4204 1338 397 
StdDev DIFF amplitude (nV RMS) ± 218 ± 107 ± 80 





Figure 29: Participant 3’s 525 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the 
right ear at 94, 84, and 74 dB peSPL. Plots B, D, and F, represent zoomed-in versions of the waveforms in A, 
C, and E respectively. The bold traces represent the mean overlaid waveform (n=2718) derived from 302 














































































F. 74 dB peSPL
Participant 3 - 525 Hz (right)
1 cycle. Blue = DIFF. Red = ANOW
Table 7: Mean (± standard deviation) RMS amplitudes for Participant 3’s 525 Hz 
right-ear ANOW and DIFF waveforms at three intensity levels. 
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The data from participant Three indicated the ANOW was present for 525 Hz in her 
right ear. Presence of the CM can be seen in all recorded cases in the DIFF waveform, seen in 
figure 29. At 525 Hz, the presence of the CM occurs from around 397 nV RMS, with increasing 
amplitude from 74 dB peSPL. At 525 Hz, the presence of the ANOW can be distinguished from 
the noise floor at 84 dB peSPL (but not 74 dB peSPL), first appearing with an amplitude of 
around77 nV RMS, as seen in figure 30. 
Figure 30: Input/output functions for Participant 3’s 525 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). The 













Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)















Participant 3 - 525 Hz (right) 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)




level (dB peSPL) 94 84 74 
Mean ANOW amplitude (nV RMS) 102 58 35 
StdDev ANOW amplitude (nV RMS) ± 28 ± 14 ± 9 
Mean DIFF amplitude (nV RMS) 1398 507 197 
StdDev DIFF amplitude (nV RMS) ± 159 ± 62 ± 41 
n (sub-averages) 9 9 9 
 
Table 8: Mean (± standard deviation) RMS amplitudes for Participant 3’s 525 Hz left-ear 
ANOW and DIFF waveforms at three intensity levels. 
 
Figure 31: Participant 3’s 525 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the 
left ear at 74, 84, and 94 dB peSPL. Plots B, D, and F, represent zoomed-in versions of the waveforms in A, C, 
and E respectively. The bold traces represent the mean overlaid waveform (n=2733) derived from 302 























































































F. 74 dB peSPL
Participant 3 - 525 Hz (left)





The data from participant Three indicated the ANOW was present for 525 Hz in her 
left ear. Presence of the CM can be seen in the DIFF waveform, seen in figure 31. At 525 Hz, 
the presence of the CM occurs significantly above the noise floor from around 200 nV RMS, 
with increasing amplitude from 74 dB peSPL. In this case, the SPL was not reduced enough to 
record the CM reduced to the level of the noise floor. At 525 Hz in the left ear, the presence 
of the ANOW can be faintly distinguished from the noise floor at the lowest level tested – 74 
dB peSPL – with an amplitude of around 35 nV RMS, as seen in figure 32. 
 
 



































Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)



















Participant 3 - 525 Hz Left 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)
ANOW noise floor (nV RMS)
Figure 32: Input/output functions for Participant 3’s 525 Hz left-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). 






level (dB peSPL) 105 95 85 
Mean ANOW amplitude (nV RMS) 106 66 52 
StdDev ANOW amplitude (nV RMS) ± 12 ± 15 ± 18 
Mean DIFF amplitude (nV RMS) 2563 499 224 
Table 9: Mean (± standard deviation) RMS amplitudes for Participant 3’s 725 Hz 
right-ear ANOW and DIFF waveforms at three intensity levels. 
Figure 33: Participant 3’s 725 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the right ear 
at 105, 95, and 85 dB peSPL. Plots B, D, and F, represent zoomed-in versions of the waveforms in A, C, and E 
respectively. The bold traces represent the mean overlaid waveform (n=3948 approx.) derived from around 300 









































































F. 85 dB peSPL
Participant 3 - 725 Hz (right)
1 cycle. Blue = DIFF. Red = ANOW
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StdDev DIFF amplitude (nV RMS) ± 118 ± 63 ± 62 
n (sub-averages) 13 13 13 
 
 
The data from participant Three indicated the ANOW was present for 725 Hz in her 
right ear. Presence of the CM can be seen in all recorded cases in the DIFF waveform, seen in 
figure 33. At 725 Hz, the presence of the CM occurs from around 224 nV RMS, with increasing 
amplitude from 85 dB peSPL. At 725 Hz, the presence of the ANOW can be distinguished from 
the noise floor at the lowest level tested – 85 dB peSPL – with the amplitude of around 52 nV 
RMS, as seen in figure 34. 
 
Figure 34: Input/output functions for Participant 3’s 725 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). 














Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)

















Participant 3 - 725 Hz (right) 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)





level (dB peSPL) 105 95 85 
Mean ANOW amplitude (nV RMS) 50 50 39 
StdDev ANOW amplitude (nV RMS) ± 18 ± 9 ± 13 
Mean DIFF amplitude (nV RMS) 694 270 117 
StdDev DIFF amplitude (nV RMS) ± 76 ± 80 ± 54 
n (sub-averages) 13 13 13 
Table 10: Mean (± standard deviation) RMS amplitudes for Participant 3’s 725 Hz 
left-ear ANOW and DIFF waveforms at three intensity levels. 
Figure 35: Participant 3’s 725 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the 
left ear at 105, 95, and 85 dB peSPL. Plots B, D, and F, represent zoomed-in versions of the waveforms in A, 
C, and E respectively. The bold traces represent the mean overlaid waveform (n=3948 approx.) derived from 
























































































F. 85 dB peSPL
Participant 3 - 725 Hz (left)




The data from participant Three indicated the ANOW was present her left ear at 725 
Hz. Presence of the CM can be seen in all recorded cases in the DIFF waveform, seen in figure 
37. At 725 Hz, the presence of the CM occurs from around 117 nV RMS, with increasing 
amplitude from 85 dB peSPL. At 725 Hz, the presence of the ANOW can be distinguished from 
the noise floor at the lowest level tested – 85 dB peSPL – with an amplitude of 39 nV RMS, as 
seen in figure 36. 
 
 
Figure 36: Input/output functions for Participant 3’s 725 Hz left-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). 














Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)




















Participant 3 - 725 Hz (left) 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)
ANOW noise floor (nV RMS)
69 
 
3.2.4 Case Four 
 Participant Four was a 54 year old female. She presented to the otolaryngologist in 
late 2015 with a vertigo attack with right beating nystagmus. She has had a history of vertigo 
attacks, as well as headaches, and a history of migraine attacks. In 2003 she had a left blind 
sac closure, which closed off her left ear canal. An MRI scan revealed nothing specific for 
causing her vertigo attacks in either ear. It was suspected that one or both of her ears may 
have been causing Meniere’s symptoms, resulting in the ECochG testing of her right ear. The 
left ear was unable to be tested in this manner. Tympanometry from her right ear revealed a 
Type Ad tympanogram, suggesting hypermobile middle ear functioning. The Left ear was 
unable to be tested due to the blind sac closure. Audiometry reveal a slight to mild sloping to 
a moderately severe sensorineural hearing loss in the high frequencies in her right ear. The 
left ear had no recordable hearing via pure tone air conduction testing at the limits of the 
audiometer. Bone conduction in the left ear was presented to the maximum before 
vibrotactile response was reported. Audiometry results are presented in figure 37. ECochG 
testing using click stimuli showed no significant increase in the SP/AP ratio in either ear. 
ECochG testing using tone bursts stimuli showed no significant increase in the SP amplitude 
at any frequency as per Gibson’s norms. The overall pattern of results is consistent with no 
hydrops in her right ear. She was referred for MRI inner ear imaging with intravenous 
gadolinium testing to determine the state of the left ear.  The ECochG results for her right ear 
are presented in table 11. 
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Table 11: Participant Four’s ECochG Results 
 
500 Hz 1000 Hz 2000 Hz 4000 Hz 
Tone 
Bursts 
Right SP Amp (μV) - 4.98 2.12 0.82 
Gibson Sig. Level (μV) 2.0 6.0 5.0 5.0 
AP Amp (μV) 4.44 7.36 10.64 11.52 
SP/AP ratio (%) - 67.7% 19.9% 7.1% 
Left SP Amp (μV) - - - - 
Gibson Sig. Level (μV) - - - - 
AP Amp (μV) - - - - 
SP/AP ratio (%) - - - - 
Clicks Right SP Amp (μV) 10.0 
AP Amp (μV) 71.7 
SP/AP ratio (%) 13.95 
Left SP Amp (μV) - 
AP Amp (μV) - 
SP/AP ratio (%) - 
 
Figure 37: Participant Four’s audiological results. The right ear showing a slight to mild sensorineural hearing loss 
sloping to moderately severe in the high frequencies. The left ear tested with no recordable hearing at the 






level (dB peSPL) 73.8 63.8 53.8 
Mean ANOW amplitude (nV RMS) 118 66 30 
StdDev ANOW amplitude (nV RMS) ± 33 ± 18 ± 7 
Mean DIFF amplitude (nV RMS) 455 152 96 
StdDev DIFF amplitude (nV RMS) ± 167 ± 70 ± 29 
n (sub-averages) 6 6 6 
Table 12: Mean (± standard deviation) RMS amplitudes for Participant 4’s 360 Hz 
right-ear ANOW and DIFF waveforms at three intensity levels. 
Figure 38: Participant 4’s 360 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the 
right ear at 74, 64, and 54 dB peSPL. Plots B, D, and F, represent zoomed-in versions of the waveforms in A, 
C, and E respectively. The bold traces represent the mean overlaid waveform (n=1852 approx.) derived from 






























































































F. 54 dB peSPL
Participant 4 - 360 Hz (right)




The data from participant Four indicated the ANOW was present for 360 Hz in her 
right ear. Presence of the CM can be seen in all recorded cases in the DIFF waveform, seen in 
figure 38. At 360 Hz, the presence of the CM occurs from around 100 nV RMS, with increasing 
amplitude from 54 dB peSPL. At 360 Hz, the presence of the ANOW can faintly be 
distinguished from the noise floor at 54 dB peSPL, with an amplitude of 30 nV RMS, as seen 
in figure 39. 
Figure 39: Input/output functions for Participant 4’s 360 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). 
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Participant 4 - 360 Hz (right) 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)





Figure 40: Participant 4’s 525 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the 
right ear at 84, 79, 74, 69, 64 and 59 dB peSPL. Plots B, D, F, H, J and L, represent zoomed-in versions of the 
waveforms in A, C, E, G, I and K respectively. The bold traces represent the mean overlaid waveform (n=2733 


































































































































































L. 59 dB peSPL
Participant 4 - 525 Hz (right)




level (dB peSPL) 84.4 79.4 74.4 69.4 64.4 59.4 
Mean ANOW amplitude (nV RMS) 125 148 56 49 45 34 
StdDev ANOW amplitude (nV RMS) ± 39 ± 35 ± 25 ± 23 ± 15 ± 11 
Mean DIFF amplitude (nV RMS) 855 638 496 391 222 148 
StdDev DIFF amplitude (nV RMS) ± 108 ± 96 ± 116 ± 137 ± 79 ± 52 
n (sub-averages) 9 9 9 9 9 9 
The data from participant Four indicated the ANOW was present for 525 Hz in her 
right ear. Presence of the CM can be seen in all recorded cases in the DIFF waveform, seen in 
figure 40. At 525 Hz, the presence of the CM occurs from around 150 nV RMS, with increasing 
amplitude from 59 dB peSPL. In this case, the recording did not show the CM reducing to the 
level of the noise floor at 29 nV. At 525 Hz in the right ear, the amplitude of the ANOW 
Figure 41: Input/output functions for Participant 4’s 525 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). 


































Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)
















Participant 4 - 525 Hz 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)
Noise floor (29 nV RMS)
Table 13: Mean (± standard deviation) RMS amplitudes for Participant 4’s 525 Hz right-ear ANOW and DIFF 
waveforms at six intensity levels. 
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Figure 42: Participant 4’s 725 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the 
right ear at 95, 90, 85, 80, 75, and 70 dB peSPL. Plots B, D, F, H, J, and L, represent zoomed-in versions of the 
waveforms in A, C, E, G, I, and K respectively. The bold traces represent the mean overlaid waveform (n=2733 







































































































































































L. 70 dB peSPL
Participant 4 - 725 Hz (right)
1 cycle. Blue = DIFF. Red = ANOW
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level (dB peSPL) 95.2 90.2 85.2 80.2 75.2 70.2 
Mean ANOW amplitude (nV RMS) 174 150 76 54 42 37 
StdDev ANOW amplitude (nV RMS) ± 51 ± 56 ± 37 ± 27 ± 24 ± 8 
Mean DIFF amplitude (nV RMS) 798 649 449 322 131 117 
StdDev DIFF amplitude (nV RMS) ± 103 ± 181 ± 161 ± 137 ± 35 ± 57 
n (sub-averages) 13 13 13 13 13 13 
 
The data from participant Four indicated the ANOW was present for 725 Hz in her 
right ear. Presence of the CM can be seen in all recorded cases in the DIFF waveform, seen in 
figure 42. At 725 Hz, the presence of the CM occurs from around 120 nV RMS, with increasing 
amplitude from 70 dB peSPL. In this case, the recording did not show the CM reducing to the 
level of the noise floor at 29 nV. At 725 Hz, the presence of the ANOW can be seen 
distinguishing from the noise floor between 80 and 85 dB peSPL, around 54 and 76 nV RMS, 
Figure 43: Input/output functions for Participant 4’s 725 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). 
The figure shows the ANOW waveform emerging above the 29 nV noise floor between 75 and 80 
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Participant 4 - 725 Hz 
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Mean ANOW amplitude (nV RMS)



















Table 14: Mean (± standard deviation) RMS amplitudes for Participant 4’s 725 Hz right-ear ANOW and DIFF waveforms 
at six intensity levels. 
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as seen in figure 43. The waveforms in figure 44 show the presence of a slight latency shift to 
the left visible in the DIFF waveform in the top figure, and a small latency shift to the right 



























725 Hz conrar DIFF (blue) and ANOW (red) 
1 cycle - 70.2 to 95.2 dB peSPL
Figure 44: Participant Four’s 725 Hz, right ear responses of the DIFF (blue) and ANOW (red) from all the levels 




Figure 45:  The mean (± st.dev) peak latencies for Participant 4’s 725 Hz DIFF (negative peaks, blue) 
and ANOW (positive peaks, red) waveforms recorded between 80 and 95 dB peSPL. 
 
Figure 46:  The DIFF wave negative peak latencies (blue trace), the ANOW positive peak latencies 
(red trace), and the latency difference between the two peaks (green trace). Measurements taken 
from the sub-averages (n = 300) that formed the waveforms shown in the previous figure. 
 
As shown in Figure 45 above, the peak latencies for the DIFF waves (blue trace) 
decreased with increasing sound level at a rate of 17.4 µs/dB. By contrast, the ANOW peak 
latencies (red trace) actually increased with increasing sound level at a rate of 3.2 µs/dB – a 
trend which is unusual for a neural waveform – however, this value must be interpreted with 
0.81 ± 0.03 ms0.78 ± 0.02 ms
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0.41 ± 0.06 ms
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caution given the large error bars at the lower sound levels. If we assume that the phasic 
neural activity that gives rise to the ANOW is actually triggered by the hair cell potentials that 
give rise to the DIFF waveform, it makes sense to account for the latency function of the DIFF 
waveform when examining the ANOW waveform. This can be achieved by simple subtraction, 
as shown in Figure 46, where the latency difference between the two peaks (green trace) 
increased with increasing sound level at a rate of 20.6 µs/dB. However, once again, the large 
error bars on the DIFF and ANOW estimates indicate that further investigation of this issue 
(ideally with waveforms with higher signal-to-noise ratios) is warranted. 
3.2.5 Case Five 
 Participant Five was a 51 year old male. He presented with a sudden hearing loss to 
his left ear, coupled with a vertigo attack in late 2014. He has previously has a vertigo attack 
25 year prior to the current episode, but had none in between. He also commented on the 
humming tinnitus that was present in his left ear. He was given prednisone for the sudden 
hearing loss, which helped to improve the loss. The MRI scan showed no abnormality in either 
ear. He then presented with another two vertigo attacks, with the possibility of left aural 
fullness in early and mid- 2015. He had ongoing nausea and fluctuating hearing loss since his 
last attacks. Clinical vestibular ocular reflex testing was normal suggesting good peripheral 
vestibular functioning. Tympanograms showed Type A bilaterally, indicating normal middle 
ear functioning. Audiometry revealed essentially normal hearing in his right ear, and a 
moderate sloping to severe sensorineural hearing loss in his left ear. Audiometry results are 
presented in figure 47. Given his symptoms he presented with suspected Ménière’s disease 
in his left ear. ECochG testing using click stimuli showed no significant increase in the SP/AP 
ratio in either ear. ECochG testing using tone bursts stimuli showed a significant increase in 
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Table 15: Participant Five’s ECochG Results 
the SP amplitude at 500 Hz, 1000 Hz, 2000 Hz, and 4000 Hz in the left ear only, as per Gibson’s 
norms. The overall pattern of results is consistent with hydrops in the left ear only. The 
ECochG results are presented in table 15. 
500 Hz 1000 Hz 2000 Hz 4000 Hz 
Tone 
Bursts 
Right SP Amp (μV) 0.0 3.5 3.0 3.80 
Gibson Sig. Level (μV) 2.0 6.0 9.0 9.0 
AP Amp (μV) 1.0 4.3 3.8 4.06 
SP/AP ratio (%) - 81.4% 78.9% 93.6% 
Left SP Amp (μV) 2.72 37.00 11.84 4.0 
Gibson Sig. Level (μV) 1.0 3.0 5.0 5.0 
AP Amp (μV) 3.88 26.0 12.06 7.0 
SP/AP ratio (%) 70.1% 142% 98.2% 57.1% 
Clicks Right SP Amp (μV) 4.14 
AP Amp (μV) 13.92 
SP/AP ratio (%) 29.74 
Left SP Amp (μV) 14.00 
AP Amp (μV) 34.30 
SP/AP ratio (%) 40.82 
 
 
Figure 47: Participant Five’s audiological results; right ear showing essentially normal hearing, the left 

























































































































































L. 49 dB peSPL
Participant 5 - 360 Hz (right)
1 cycle. Blue = DIFF. Red = ANOW
Figure 48: Participant 5’s 360 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the right ear 
at 49, 54, 59, 64, 69 and 74 dB peSPL. Plots B, D, F, H, J and L, represent zoomed-in versions of the waveforms in A, 
C, E, G, I and K respectively. The bold traces represent the mean overlaid waveform (n=2733) derived from 302 




level (dB peSPL) 73.8 68.8 63.8 58.8 53.8 48.8 
Mean ANOW amplitude (nV RMS) 22 20 22 19 21 17 
StdDev ANOW amplitude (nV RMS) ± 4 ± 4 ± 7 ± 3 ± 5 ± 3 
Mean DIFF amplitude (nV RMS) 78 68 54 45 44 40 
StdDev DIFF amplitude (nV RMS) ± 18 ± 15 ± 22 ± 15 ± 10 ± 3 
n (sub-averages) 22 20 22 19 21 17 
 
 
The data from participant Five indicated the ANOW was not present for 360 Hz in his 
right ear. Presence of the CM can be seen in all recorded cases in the DIFF waveform, seen in 
figure 48. At 360 Hz, the presence of the CM occurs from around 40 nV RMS, with increasing 
amplitude from 49 dB peSPL. The CM does not reduce to the level of the noise floor. At 360 
























Mean DIFF amplitude (nV RMS)
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Participant 5 - 360 Hz Right 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)
Noise floor (nV RMS)
Figure 49: Input/output functions for Participant 5’s 360 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). The 
figure shows the ANOW waveform and the average noise floor 19 nV, which does not appear below 74 
dB peSPL. 
Table 16: Mean (± standard deviation) RMS amplitudes for Participant 5’s 360 Hz right-ear ANOW and DIFF waveforms 
at six intensity levels. 
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Hz, the presence of the ANOW cannot be distinguished from the noise floor at 19 nV, as seen 

























































































































































L. 59 dB peSPL
Participant 5 - 525 Hz (right)
1 cycle. Blue = DIFF. Red = ANOW
Figure 50: Participant 5’s 725 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the right ear 
at 45, 55, 65, 75 and 85 dB peSPL. Plots B, D, F, H, J and L, represent zoomed-in versions of the waveforms in A, C, E, 
G, I and K respectively. The bold traces represent the mean overlaid waveform (n=2733) derived from 302 stimulus 
presentations. The light traces are the mean of 302 presentations. 
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level (dB peSPL) 84.4 79.4 74.4 69.4 64.4 59.4 
Mean ANOW amplitude (nV RMS) 22 17 19 20 22 18 
StdDev ANOW amplitude (nV RMS) ± 5 ± 5 ± 5 ± 4 ± 6 ± 2 
Mean DIFF amplitude (nV RMS) 174 78 66 30 40 30 
StdDev DIFF amplitude (nV RMS) ± 28 ± 22 ± 18 ± 12 ± 13 ± 10 
n (sub-averages) 9 9 9 9 9 9 
 
 
The data from participant Five indicated the ANOW was not present for 525 Hz in his 
right ear. Presence of the CM can be seen in the DIFF waveform, seen in figure 50. At 525 Hz, 
the presence of the CM can be seen emerging from the noise floor between 69 and 74 dB 
peSPL. At 525 Hz, the presence of the ANOW cannot be distinguished from the noise floor at 
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Participant 5 - 525 Hz Right 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)
Noise floor (nV RMS)
Figure 51: Input/output functions for Participant 5’s 525 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). The 
figure shows the ANOW waveform and the average noise floor 20 nV, which does not appear below 84 
dB peSPL. 
Table 17: Mean (± standard deviation) RMS amplitudes for Participant 5’s 525 Hz right-ear ANOW and DIFF waveforms 






















































































































































L. 45 dB peSPL
Participant 5 - 725 Hz (right)
1 cycle. Blue = DIFF. Red = ANOW
Figure 52: Participant 5’s 525 Hz overlaid single-cycle DIFF (blue) and ANOW (red) waveforms elicited in the 
right ear at 49, 54, 59, 64, 69 and 74 dB peSPL. Plots B, D, F, H, J and L, represent zoomed-in versions of the 
waveforms in A, C, E, G, I and K respectively. The bold traces represent the mean overlaid waveform (n=2733) 




level (dB peSPL) 85.2 75.2 65.2 65.2 55.2 45.2 
Mean ANOW amplitude (nV RMS) 20 21 19 23 20 24 
StdDev ANOW amplitude (nV RMS) ± 3 ± 7 ± 4 ± 3 ± 4 ± 5 
Mean DIFF amplitude (nV RMS) 118 54 52 43 41 30 
StdDev DIFF amplitude (nV RMS) ± 20 ± 22 ± 13 ± 22 ± 11 ± 10 




The data from participant Five indicated the ANOW was not present for 725 Hz in his 
right ear. Presence of the CM cannot be seen in all recorded cases in the DIFF waveform, seen 
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Participant 5 - 725 Hz Right 
Mean DIFF amplitude (nV RMS)
Mean ANOW amplitude (nV RMS)
Noise floor (nV RMS)
Figure 53: Input/output functions for Participant 5’s 725 Hz right-ear DIFF (blue) and ANOW (red) 
waveforms respectively, shown on a linear amplitude scale (top) and a logarithmic one (bottom). The 
figure shows the ANOW waveform and average the noise floor 20 nV, which does not appear below 85 
dB peSPL. 
Table 18: Mean (± standard deviation) RMS amplitudes for Participant 5’s 725 Hz right-ear ANOW and DIFF waveforms 
at six intensity levels. 
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At 725 Hz, the presence of the ANOW cannot be distinguished from the noise floor at 20 nV, 
as seen in figure 53.  
The overall data from this participant indicated no ANOW presence above the noise 
floor for 360, 525, or 725 Hz in the right ear. The left ear was not tested due to participant 
time constraints. Presence of the CM can be seen in all recorded case in the DIFF waveform. 
3.3 Comparison of ANOW processing strategies 
All published accounts of the processing strategies used to extract the ANOW make 
reference to the use of both condensation (CON) and rarefaction (RAR) stimuli. In our 
implementation, this method makes use of long tone-bursts (approx. 30 ms in duration) 
delivered at approximately 18 stimuli/second. To generate an ANOW waveform by averaging 
responses to 300 CON and RAR stimuli therefore takes 33.3 seconds per frequency/intensity 
combination, or 10 minutes for three frequencies at six sound levels. 
We hypothesised that if we were to consider the centre portion of the waveform, 
there would be a negligible difference between the first half-cycle of a DIFF waveform elicited 
by a condensation stimulus and the second half-cycle of a DIFF waveform elicited by a 
rarefaction stimulus. As long as there was no onset CAP present, the only difference between 
the two half-cycles would be a 180 degree phase shift. It could therefore be possible to halve 
the acquisition time for the ANOW by utilising waveforms evoked by only CON or RAR stimuli, 
not both. 
To test this hypothesis, we compared DIFF and ANOW waveforms generated from 
CON and RAR stimuli (“CONRAR”), CON stimuli only (“CONshiftCON”), and RAR stimuli only 
(“RARshiftRAR”). For the CONshiftCON method, we replaced the RAR-evoked waveform with 
the CON-evoked waveform shifted by half a cycle. Similarly, the RARshiftRAR trace was 
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generated after replacing the CON-evoked waveform by the half-cycle-shifted RAR-evoked 
waveform. 
As shown in Figure 54, there is very few differences visible between the responses 
recorded with the three different techniques, but the two shifted methods have the 
























B. 94 dB peSPL
Participant 3 - 525 Hz - CONRAR
























D. 94 dB peSPL
Participant 3 - 525 Hz - CONshiftCON
























F. 94 dB peSPL
Participant 3 - 525 Hz - RARshiftRAR
Left ear. 1 cycle. Blue = DIFF. Red = ANOW
Figure 54: The comparisons of the different processes used to produce the ANOW  
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waveforms were 1398 ± 159 nV, 1393 ± 88 nV, and 1421 ± 200 nV for CONRAR, CONshiftCON 
and RARshiftRAR respectively. The measured RMS amplitudes of the ANOW waveforms were 
102 ± 28 nV, 107 ± 43 nV, and 87 ± 30 nV for CONRAR, CONshiftCON and RARshiftRAR 
respectively, with respective noise floors of 29, 27, and 33 nV RMS. 
3.4 Discussion 
 Overall, comparing the data analysed to the audiograms of the participants, we cannot 
conclude at this stage that the ANOW that we have measured is purely apical cochlea neural 
responses. Although we have not yet been able to convert the dB peSPL values calculated to 
dB HL, we can say that it is unlikely at this stage that the values represent the lower frequency 
hearing thresholds. For example, Participant Three, who has normal hearing between 360 and 
725 Hz does not present with an ANOW until around 80 dB peSPL. This, when more accurately 
converted to dB HL, would more likely present as thresholds of her higher frequencies, 
approximately around 4000 Hz in her right ear. Similar findings can be seen with the 
Participant Four, with her ANOW responses closer in threshold response to around 4000 Hz, 
rather than representing her lower frequencies. Patuzzi, Yates, & Johnstone (1989) found that 
the CM for an intense low frequency tone came from the base, rather than the apex, of the 
guinea pig cochlea. Similar findings may be the case here, and further investigation needs to 
be undertaken, focusing on this area. From these results we can conclude that we are unable 
to show that the ANOW responses that we have recorded are purely apical cochlea responses 
in origin. To show this in the future, masking would be required to show frequency specificity 
and purely neural responses, with no interference from possible non-neural contributors, 
such as the OHCs.  
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 Further calibrations need to be conducted to accurately convert dB peSPL to dB HL, 
for an accurate threshold comparison. Due to time constraints, this process was unable to be 
completed in time, but some conclusions could be made about the approximate threshold it 
would relate to, with an estimated 15 dB difference maximum between the dB peSPL and dB 
HL values. This allowed some conclusions to be drawn about the DIFF and ANOW responses 
in relation to participant threshold. At this stage of the research, lacking accurate threshold 
comparison from our given results, as well as the accuracy of the frequency selectivity, we 
cannot reliably draw conclusions in relation to the participant’s ECochG and Ménière’s results. 
 Latency and amplitude changes with increased stimulation can be seen for the CM 
responses throughout the data of the participants, such as in Figure 44 from Participant Four 
725 Hz, right ear responses. This change (decrease in latency, increase in amplitude with 
increased stimulation), can be seen with many other neural responses, such as ABR and 
ECochG (Eggermont, 1974; Hecox & Galambos, 1974). Chertoff, Lichtenhan, & Willis (2010) 
also investigated into the amplitude and latency functions of human CAPs using different 
stimuli of clicks and chirps. They too found similar neural responses of the decrease in latency 
with increase in stimulus level, as well as increase in amplitude with increase in stimulus level. 
However the different compositions of the stimuli altered the significance of the latency and 
amplitude changes with stimulus. The chirp was found to have greater increase in amplitude 
compared to the click stimuli, which can be seen in figure 55. The chirp was also found to have 
a shallower latency than the click with increased stimulus, as seen in figure 56. They explain 
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this finding as being due to the nature of the chirp, causing greater neural firing in unison, as 
compared to the click stimulus (Chertoff, Lichtenhan, & Willis, 2010).  
Latency and amplitude changes as seen with Participant Four’s 725 Hz right ear DIFF 
waveform in may be caused by neural similar neural effects as those discussed in Chertoff, 
Lichtenhan, & Willis (2010). As discussed in the results, the peak latencies for the DIFF waves 
(blue trace) decreased with increasing sound level, while the ANOW peak latencies (red trace) 
Figure 55: Amplitude of click (black) compared to chirp (white) stimuli on N1 (CAP) responses 
with change in signal level (Chertoff, Lichtenhan, & Willis, 2010). 
Figure 56: Latency of click (circle) compared to chirp (square) stimuli on N1 (CAP) responses with 
change in signal level (Chertoff, Lichtenhan, & Willis, 2010). 
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increased with increasing sound level. This aspect of the latency trend of the ANOW was not 
expected, and does not fit with the evidence base seen around neural waveform latency 
trends. This result should take into consideration the large error bar at lower sound levels, 
which may be giving erroneous information regarding the latency trend seen. Further 
investigation into this area of the study will be required before any solid conclusions can be 
drawn. This also may help to explain the origin of the generators of the DIFF and ANOW 
waveforms. We cannot say with certainty the origins of the waveforms that we recorded, 
however the latency and amplitude changes observed may help to indicate possible 
generators, and in future research may show that the DIFF is produced solely from the OHCs, 
while the ANOW is truly neural in origin.  
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Chapter Four: Discussion 
The current study aimed to develop the use of the ANOW in humans, specifically in 
those with Ménière’s disease. We collected normative data from the participants with 
suspected Ménière’s disease, which we used to compare to their subjective thresholds, and 
their ECochG responses. The findings, described in the previous chapter, do not fully support 
our hypothesis that the ANOW monitoring technique can accurately predict thresholds at 
lower frequencies. We also attempted to compare both neural and hair cell functioning 
through the comparison of the CM and the ANOW measured in the participants. These 
findings are promising, but do lead to further changes that need to be made to show 
frequency selectivity and evidence of purely neural responses from the ANOWs. From these 
findings we can begin to further develop a clinically viable low frequency monitoring 
technique through further research. 
4.1 Limitations  
The first point to be discussed about this study and its predominant findings, is that all the 
participants were suspected of having Ménière’s disease, and at the very least had inner ear 
or vestibular system abnormalities requiring invasive ECochG testing. Taking this into account, 
our results cannot be used as normative data, as the subject ears cannot be defined as normal. 
The sample size of this study should also be taken into consideration. The sample size of five 
participants is a good starting point to further investigate the clinical usefulness of the ANOW, 
but the clinical implications from this data cannot be drawn. The case study data that we have 
collected has shown that the procedure can be done and produce viable results. 
The second, more predominant limitation for this study is the idea that what we recorded 
was neural in origin. The ANOW has been discussed earlier, and has been proven in the 
Lichtenhan, Hartsock, Gill, Guinan Jr, and Salt (2014) to be neural in origin, by injecting 
96 
 
tetrodotoxin into the cochlea apex of guinea pigs, and measuring the hair cell (CM) and neural 
(ANOW) responses as the toxin took effect. This showed that ANOW was purely neural in 
origin. However it is impossible to conduct the same research as Lichtenhan et al. (2014) due 
to the nature of our participants (i.e. they were human). Lichtenhan et al. (2014) sought to 
disprove the “alternate possibilities… …that ANOW originates from the excitation of low-
frequency tails of high-characteristic frequency auditory nerve fibers or from distortion in the 
cochlear microphonic (CM).” Our work has not been able to do this. 
While Lichtenhan et al. (2014) concluded that the ANOW elicited with low-to-moderate 
level sounds (i.e. below 65 dB SPL) is a neural measure from the cochlear apex, they observed 
with regard to high-level sound that “[the putative ANOW] from low-frequency high-level 
sounds originates, at least in part, from sources that are not neural action potentials” which 
suggests that “ANOW is not a suitable name for [the putative ANOW] at high sound levels” 
because “CM distortion can be an important origin of [the putative ANOW] from high-level 
sound”. However, it must be remembered that these limitations apply to the guinea pig, not 
humans.  
We can however, in future studies, apply the use of stacked masking, to not only reduce 
the likelihood of non-neural high frequency interference, but also prove the select 
characteristic frequency of the ANOW being produced. Stacked masking noise can be used by 
producing high pass filtered noise at selected frequencies to eliminate contributing neural 
responses from the basal turn of the cochlea. This will result in a tone which is neural and 
specific. The stacked masking can be applied from previous other methods, as seen with the 
derived band measurement of the CAP and ABR. 
The derived band ABR measurement comes from the paper developed by Don, Masuda, 
Nelson, and Brackmann (1997). Auditory brainstem responses and compound action 
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potentials have both been shown to be neural activity initiated in the brainstem by cochlear 
activation over time, and does not necessarily represent the specific placement along the 
cochlea that has been stimulated (Don & Eggermont, 1978; Eggermont & Don, 1980; Elberling, 
1978). Don et al. (1997) developed the derived band ABR technique to specifically measure 
the response from a characteristic frequency using masking. The technique measures the ABR 
response using a high pass filtered masking noise to create ABR responses of a characteristic 
frequency. These characteristic frequency responses are the derived bands, which are created 
by successive subtraction of the responses obtained from the progressive high pass masking 
applied. See figure 57 for a pictorial representation of the derived band ABR measurement 
(Don et al., 1997). From this Don et al. (1997) found that by stacking the waveform, that the 
response is improved. This can be seen in figure 58. The idea of stacked derived band ABR 
measurement can be applied to the current study, where the use of high pass filtered masking 
can be applied to obtain an ANOW that is a specific characteristic frequency, but also shown 
to be neural in origin. 
4.2 Directions for Future Research 
Future endeavours of this study should include the addition of stacked derived ANOW 
masking, as well as a larger participant sample, as previously stated. Further sample selections 
should include participants with normal auditory system functioning. Sampling participants 
who do not require transtympanic ECochG may be problematic, and the method of electrode 
recording may have to change. Development of extratympanic recording would assist in this 
area. Preliminary trials that were conducted with the study did not have success with 
recording any auditory responses using Sanibel™ TM Electrode for ECochG electrodes. These 
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recordings were attempted in a similar manner to how the transtympanic protocols were 
carried out, but using the researchers as participants. The results did not yield any measurable 
results, and was decided that this method, for the purposes of this study, was not viable. 
There is a vast amount of evidence to suggest that the extratympanic method of recording is 
feasible, practical, and a potential for future research endeavours (Bonucci & Hyppolito, 2009; 
Schoonhoven, Fabius, & Grote, 1995). 
Figure 57: shows the derived band measurement 
for obtaining specific characteristic frequency ABRs. 
High pass masking is applied sequentially (left hand 
column), and subtracted from the previously 
acquired response to obtain the derived band 
measurement (right column). Taken from Don et al., 
(1997). 
Figure 58: shows the derived band ABR measurement 
(left), and the stacked derived band ABR 
measurement (right) in comparison. Taken from Don 
et al., (1997). 
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 The other possibility of future research involves recording the ANOW in the electrically 
and acoustically challenging operating theatre environment. Previous attempts to record the 
ANOW during surgery within this study were also unsuccessful due to the difficulty of finding 
the source of electrical noise within the operating room. In the prior study, all attempts were 
taken to reduce the electrical noise but ultimately it was unsuccessful. Future research in this 
area, could include development of threshold seeking using the ANOW within the surgical 
environment. 
4.3 Clinical Implications 
 The main clinical application that the ANOW now provides, is the ability to objectively 
measure low frequency thresholds, where no other method successfully does. The main 
concerns with ECochG components of the CAP and the SP, the ABR, and OAEs is that they do 
not monitor 500 Hz and below well, and in some cases even 1000 Hz and below (Gorga et al., 
1993; Laureano, McGrady, & Campbell, 1995; Schoonhoven, Prijis, & Grote, 1996; Sininger, 
2007). This new method of objectively monitoring hearing at low frequencies could allow for 
a more accurate audiometric threshold estimation in such situations as new born and young 
children hearing aid fittings, intraoperative monitoring during surgeries, and an added 
diagnosis of endolymphatic hydrops in the diagnosis of Ménière’s disease. 
This method of recording could add to the diagnoses of Ménière’s disease. The current 
ECochG method lacks in accuracy in the lower frequencies (Laureano, McGrady, & Campbell, 
1995; Schoonhoven, Prijis, & Grote, 1996; Spoor & Eggermont, 1976). Further investigation is 
required to determine if hydrops are more accurately estimated with the ANOW and CM, 
than with the current ECochG method. Testing of a normal hearing population would be 
required before the use of this data could determine hydrops or other inner ear disorder’s 
effects on the ANOW recorded in this study.  
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The clinical use in operating theatres could be extended to a range of procedures. This 
could include vestibular schwannoma removal, cochlear implantation surgery, middle ear 
surgery, and in the diagnosis of Ménière’s disease. Currently in vestibular schwannoma 
surgery, the main intraoperative auditory monitoring used is ABR, ECochG, or direct eighth 
nerve monitoring, the former of which does not give real time feedback during surgery, and 
the latter requires exposure of the eighth cranial nerve.  
Choudhury et al. (2012) investigated the use of the ANN for low frequency hair cell and 
neural activity during cochlear implantation. They were able to measure some activity from 
what they assumed to be neural responses, as well as CM, CAP, and SP in several participants. 
They indicated that this could then be used to aid the cochlear implantation, and reduce the 
amount of damage caused to the cochlea and the patient’s residual hearing. Combining the 
results from our study, and adding the stacked derived ANOW masking method, to ensure the 
results are frequency specific and neural in origin, this method could be used to assist 
intraoperatively in CI surgeries. Fitzpatrick et al. (2014) used the components of ECochG in 
patient’s pre-CI, to see if cochlea responsiveness had an effect on post-CI speech outcomes. 
They measured the CAP, SP, CM, and ANN in this study, although again the ANN was not 
proven to be purely neural in response. They did find that the magnitude of the ECochG 
responses correlated to more positive speech outcomes in post lingual adults than other 
factors, such as degree of residual hearing or the period of deafness (Fitzpatrick et al., 2014). 
Many studies have found that the preservation of any residual hearing in adults, greatly 
improves sound quality and SNR for the patients (Fraysse et al., 2006; Gantz, Turner, Gfeller, 
& Lowder, 2005; James et al., 2005; Turner, Gantz, Vidal, Behrens, & Henry, 2004). 
The rate of permanent postoperative inner ear damage following otologic surgery via 
reconstructive conductive mechanisms within the middle are low, recorded as 0 – 7% 
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(Häusler, 2004), when complications do occur, they can be severe and devastating (Guyot & 
Sakbani, 2007). Intraoperative monitoring during such procedures could accurately measure 
changes in auditory function if damage occurs. It can also be used to optimise the hearing 
outcome by assisting the surgeon as to the placement of any conductive prosthesis in the 
ossicular chain (Hsu, 2011; Wazen, Emerson, & Foyt, 1997). Reported feedback of 
intraoperative monitoring to the surgeons have been less studied in cochlear implantation 
and middle ear reconstructive surgeries, than for vestibular schwannoma removal; however 
all areas of intraoperative monitoring using the ANOW are still to be investigated (Danner, 
Mastrodimos, & Cueva, 2004; Hsu, 2011; Mandalà, Colletti, Tonoli, & Colletti, 2012). 
It is well known that essentially normal hearing thresholds are important for auditory 
development in infants and young children (Boothroyd, 1997; Katz, 2009). For children with 
hearing impairment, this can mean the use of hearing devices such as hearing aids or cochlear 
implants for normal speech and language to develop. As discussed above, residual hearing 
with a cochlear implant assisted with hearing aids can be beneficial in adults. Children face 
greater difficulties than adults in this respect, as they do not have prior knowledge of language 
to assist them in discerning what they do hear, and need greater inputs of audibility than 
adults (Stelmachowicz, Pittman, Hoover, & Lewis, 2001). Added to this difficulty is the testing 
and measuring the hearing thresholds of young children. As previously mentioned, current 
methods of objectively measuring hearing thresholds do not always accurately measure low 
frequencies. This can have implications for child hearing aid fitting, as an optimal fitting means 
better acquisition of auditory sound for the child, and greater chance of normal speech and 
language development (McCreery, 2013). Identification of the correct threshold can impact 
on hearing aid fitting and therefore speech intelligibility.  Thornton and Abbas (1980) found 
that those with a hearing impairment in the lower frequencies, compared to normal hearing 
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people, were worse at distinguishing speech when a high pass masker was applied to the 
speech stimulus, but better if a low pass masker was applied. Their findings suggest that those 
with a low frequency loss are able to make use of their remaining high frequency hearing just 
as well, if not better than those with normal hearing (Thornton & Abbas, 1980). Amplification 
of the low frequencies can improve sound quality for the client and give increased loudness 
(Punch & Beck, 1986). However over amplification may result in masking the mid and higher 
frequencies needed for speech clarity (Studebaker, Sherbecoe, McDaniel, & Gwaltney, 1999). 
Over or under amplification of lower frequencies can have an effect on speech perception, 
and therefore development, making the objective measurement of low frequency hearing 
thresholds important to develop further. 
The methods of measurement of the ANOW from this study has allowed the observation 
of the responses from the OHCs by the CM, but also the neural response of the ANOW itself. 
This may lead to the development of using this method in the diagnosis of auditory 
neuropathy spectrum disorder (ANSD). ANSD is a dysfunction of the auditory nerve which has 
shown to affect temporal processing, resulting in poor speech perception (Berlin et al., 2010). 
The current methods of diagnosing ANSD involve DPOAEs, acoustic reflexes, and ABRs. The 
result for positive ANSD testing will show present DPOAEs (if normal hearing thresholds), 
absent acoustic reflexes, absent or abnormal ABRs, and also the presence of a CM (Berlin et 
al., 2010). These patients can present with normal hearing thresholds, but will struggle to 
understand speech in background noise. The methods used in this study could be developed 
as part of the test battery for diagnosing ANSD by the presence of the CM and the absence 
(or abnormality) of the ANOW in relation to the audiometric threshold. This would give an 
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Appendix A: Patient Information and Consent Forms 
 
Information Sheet 
A new method for investigating hearing in Ménière’s Disease 
You are invited to take part in a study looking at hearing and the presence of Ménière’s Disease. 
The results may provide important information regarding low-frequency hearing thresholds and the 
presence or absence of Ménière’s. 
Such information may make it possible to diagnose Ménière’s in the future and the techniques 
developed during this study may also be used to monitor low-frequency hearing during cochlear 
implant surgery. 
What is required of me if I choose to take part? 
All that will be different for you is that some extra sounds will be presented to you during your 
Electrocochleography assessment with Mr Hornibrook. 
This is expected to add no more than 30 minutes to your appointment. 
In addition to this you will complete a hearing assessment. 
 
Is there any risk to me by being involved in this study? 
The study will in no way affect your assessment with Mr Hornibrook. You can pull out of the study at 
any time and this will have no effect on your care.  
Will my GP be told I am in the study? 
It is up to you whether you would like your GP to know that you are taking part in this study. For us to 
tell your GP, you must first give us your written permission. 
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If I need an interpreter, can one be provided? 
Yes, we can organise an interpreter to help you. You will be asked if you need an interpreter if you 
choose to sign the consent form. 
Important information 
If you take part in the study your privacy and confidentiality will be protected and there will be no 
information shown to people outside the medical study staff that could be identified to you. No 
material that could personally identify you will be used in any reports on this study. 
If you have any queries or concerns regarding your rights as a participant in this study, you may wish 
to contact an independent health and disability advocate: 
Free phone: 0800 555 050 
Email: advocacy@hdc.org.nz 
This study has received ethical approval from the Upper South B Regional Ethics Committee 
(13/STH/49), and the University of Canterbury Human Ethics Committee (HEC 2012/94).  
Where can I get more information about the study? 
Please feel free to contact the researchers at any stage if you have any queries about this study (details 
listed below). 
If you would like to take part in the study, you will be given a consent form during your assessment 
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A new method for investigating hearing in Ménière’s Disease 
English I wish to have an interpreter. Yes No 
Maori E hiahia ana ahau ki tetahi kaiwhakamaori/kaiwhaka pakeha korero. Ae Kao 
Cook 
Island 
Ka inangaro au i  tetai tangata uri reo. Ae Kare 
Fijian Au gadreva me dua e vakadewa vosa vei au Io Sega 
Niuean Fia manako au ke fakaaoga e taha tagata fakahokohoko kupu. E Nakai 
Samoan Ou te mana’o ia i ai se fa’amatala upu. Ioe Leai 
Tokelaun Ko au e fofou ki he tino ke fakaliliu te gagana Peletania ki na gagana o 
na motu o te Pahefika 
Ioe Leai 
Tongan Oku ou fiema’u ha fakatonulea. Io Ikai 
 
1. I have read and I understand the information sheet for volunteers taking part in the 
above-named study. I have had the opportunity to discuss this study and have had any 
questions answered satisfactorily. 
 
2. I have had the opportunity to use whanau support or a friend to help me ask questions 
and understand the study. 
 
3. I have had this project explained to me by one of the investigators. 
 
4. I understand the aims of the study and what is required of me to participate. 
 
5. I understand that taking part in this study is voluntary (my choice) and that I may 
withdraw from the study at any time without having to give a reason, including the 
withdrawal of any information I have provided. This will in no way affect my 
future/continuing health care. 
 
6. I understand that my participation in this study is confidential and that no material 





7. I understand that the results collected in this study will be kept in a secure location for 
a period of up to 10 years. 
 
8. I understand that a suitable interpreter will be provided if necessary. 
 
9. I know who to contact if I have any questions about the study. 
 
10. I have had time to consider whether or not to participate in the study 
 
11. I would like a copy of the summarised results at the completion of the study 
 




Participant to sign: 
 
I ……………………………………..................................................................................... (full name) 
hereby consent to take part in this study to investigate a new method for investigating hearing in 
Ménière’s Disease 
Signature................................................................................  Date..............................   
 
 
Researcher to sign: 
 
I.............................................…………………………………….......................................... (full name) believe 
that consent was given freely by the participant and have witnessed the signing of the consent form 
above 
Signature................................................................................  Date..............................   
 
 
Yes   /   No 
Yes   /   No 
